Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


PLANT MATERIAL OR PLANT EXTRACT OF UNDETERMINED CONSTITUTION AS ACTIVE INGREDIENT (E.G., HERBAL REMEDY, HERBAL EXTRACT, POWDER, OIL, ETC.)

Subclass of:

424 - Drug, bio-affecting and body treating compositions

Patent class list (only not empty are listed)

Deeper subclasses:

Class / Patent application numberDescriptionNumber of patent applications / Date published
424769000 Containing or obtained from a tree having matured height of at least two meters 130
424728000 Containing or obtained from Panax or Acanthopanax (e.g., ginseng, etc.) 100
424757000 Containing or obtained from Leguminosae (e.g., legumes such as soybean, kidney bean, pea, lentil, licorice, etc.) 100
424729000 Containing or obtained from Camellia (e.g., tea, including green or black tea, etc.) 89
424727000 Containing or obtained from Palmaceae (e.g., date, coconut, saw palmetto, etc.) 67
424773000 Containing or obtained from a root, bulb, tuber, corm, or rhizome (aka radix) 66
424745000 Containing or obtained from Labiatae (e.g., oregano, marjoram, etc.) 66
424777000 Containing or obtained from a fruit (aka fructus), including berry 61
424750000 Containing or obtained from Gramineae (e.g., bamboo, corn, or grasses such as grain products including wheat, rice, rye, barley, oat, etc.) 61
424774000 Containing or obtained from a leaf (aka folium or foliage) 58
424756000 Containing or obtained from Zingiberaceae (e.g., Afromonun, cardemon, ginger, turmeric, etc.) 55
424736000 Containing or obtained from Citrus (e.g., orange, lemon, lime, grapefruit, etc.) 52
424776000 Containing or obtained from a seed or nut 47
424739000 Containing or obtained from Cinnamomum (e.g., cinnamon, etc.) 46
424744000 Containing or obtained from Aloe (e.g., aloe vera, etc.) 46
424732000 Containing or obtained from Vaccinium (e.g., bilberry, cranberry, blueberry, etc.) 46
424764000 Containing or obtained from Compositeae (e.g., marigold, sunflower, dandelion, feverfew, yarrow, chamomile, etc.) 42
424765000 Containing or obtained from Roseaceae (e.g., rose, hawthorn, meadowsweet, strawberry, raspberry, blackberry, apple, etc.) 39
424766000 Containing or obtained from Vitis (e.g., grape, grapeseed, wine from grapes, etc.) 37
424752000 Containing or obtained from Ginkgo (e.g., ginkgo biloba, maidenhair, etc.) 28
424734000 Containing or obtained from Piper (e.g., black pepper, kava-kava, etc.) 28
424735000 Containing or obtained from Prunus (e.g., prune, cherry, plum, apricot, peach, almonds, etc.) 27
424747000 Containing or obtained from Mentha (e.g., mint, peppermint, spearmint, habak, etc.) 23
424754000 Containing or obtained from Allium (e.g., onion, garlic, ramp, chive, scallion, etc.) 20
424740000 Containing or obtained from Artemisia (e.g., wormwood, absinthe, etc.) 20
424778000 Containing or obtained from a flower or blossom (aka flos) 19
424737000 Containing or obtained from Echinacea (e.g., coneflower, etc.) 19
424742000 Containing or obtained from Eucalypti (e.g., eucalyptus, etc.) 18
424730000 Containing or obtained from Hypericum (e.g., St. John's wort, etc.) 18
424755000 Containing or obtained from Brassica (e.g., horseradish, mustard, etc.) 15
424738000 Containing or obtained from Plantago (e.g., plantain, psyllium, etc.) 13
424741000 Containing or obtained from Scutallaria (e.g., scullcap, etc.) 13
424760000 Containing or obtained from Capsicum (e.g., chili pepper, cayenne pepper, red pepper, etc.) 11
424758000 Containing or obtained from Cucumbrits (e.g., gourds such as pumpkin, squash, cucumber, etc.) 11
424768000 Containing or obtained from Linaceae (e.g., flaxseed, linseed, etc.) 7
424775000 Containing or obtained from a bark (aka cortex) 7
424733000 Containing or obtained from Valeriana (i.e., Valeriana officinalis) 5
20100119630VALERIAN EXTRACT PREPARATION - Process for preparing a valerian extract formulation comprising the steps of: 05-13-2010
20110142968Nutritional supplement - A nutritional supplement useful for promoting good overall health and relieving minor aches and pains associated with inflammation and muscle soreness includes a plurality of active herbal ingredients (turmeric extract, white willow extract, passion flower extract, valerian root extract, and/or licorice root extract), a plurality of non-herbal active ingredients (magnesium glycinate, vitamin B1 (thiamine HCI), vitamin B2 (riboflavin), vitamin B3 (niacinamide), vitamin B6 (pyridoxine HCI), folic acid, vitamin B12, and/or beta carotene). The nutritional supplement may be in the form of an effervescent tablet that is dissolvable in a potable liquid and can include one or more sweeteners and flavorings.06-16-2011
20120034324ROLE OF AN HERBAL FORMULATION IN THE PREVENTION AND MANAGEMENT OF AGE RELATED NEURODEGENERATIVE DISORDERS WITH SPECIAL REFERENCE TO SENILE DEMENTIA - According to this invention there is provided a herbal formulation for the prevention and management of neurodegenerative disorders comprising, hydro-methanolic extract of at least one plant selected from 02-09-2012
20110020477ORAL PREPARATION, INJECTION PREPARATION, EXTERNAL SKIN PREPARATION AND COSMETIC METHOD FOR PREVENTING OR IMPROVING WRINKLES - Wrinkles are improved by applying an oral preparation, injection preparation or external skin preparation having a substance that controls heparanase as an active ingredient thereof.01-27-2011
20080248140COMPOSITION FOR SUPPORTING RESTFUL SLEEP - A method for promoting and supporting restful, quality sleep in an individual comprising the administration of a composition comprising Valerian root extract and Methylcobalamin.10-09-2008
424726000 Containing or obtained from Hydratis (e.g., goldenseal, etc.) 5
20100119629ANGINA PECTORIS AND ISCHEMIC HEART DISEASE AND SYNERGISTIC PHYTOCEUTICAL COMPOSITION FOR SAME - Phytoceutical compositions for the prevention and treatment of circulatory disorders, such as Angina Pectoris and Ischemic Heart Disease are taught. A specific combination of extracts of plants is taught, as well as principles for varying the formulations based on categorizing plants into one of three groups, Energy, Bio-Intelligence, and Organization and selecting several plants from each group. Such combinations have synergistic effects as demonstrated by gene expression levels, yet exhibits minimal side effects.05-13-2010
20110287115Standardization of Botanical Products Utilizing Biological Activity as a Marker - The present invention relates generally to herbal materials and methods for making such materials in medicinally useful and pharmaceutically acceptable forms. Particularly, the present invention relates generally to 11-24-2011
20100303935Medicinal Composition - A medicinal composition comprising herbal extracts of herbaceous botanicals that can help provide relief of various ailments. The medicinal composition can comprise a topical analgesic with therapeutic benefits for use in humans, equine, bovine, canine, feline, porcine, or other animals or birds for treatment, healing or relieving symptoms resulting from injured ligaments, tendons, muscles, bones, hematomas, nerves, or sports injuries or for epidermal or dermal treatment or relief of conditions or symptoms caused by arthritis, neuralgia, or pain. The herbaceous botanicals of the preferred herbal extracts of herbaceous botanicals in this application can include: 12-02-2010
20130149398COMPOSITIONS OF HERBAL FORMULATIONS AND USES THEREOF - Disclosed herein are herbal formulations for relief from symptoms of skin disease. The formulations can also be combined with an active or inactive pharmaceutical ingredient, and/or a pharmaceutically acceptable excipient.06-13-2013
20120258183MACRONUTRIENT SENSITIVITY - The present invention relates to a method and a kit for identifying a subjects macronutrient sensitivity. The method involves assaying a genetic sample from the subject to determine a polymorphism profile, analysing the polymorphism profile to identify risk alleles and determining the macronutrient sensitivity based on the number of risk alleles present. This information can be used for determining an appropriate diet to induce satiety, formulating a diet for inducing satiety, or for treating a range of medical complaints associated with metabolism.10-11-2012
424761000 Containing or obtained from Azadirechta (e.g., neem, etc.) 5
20110200696ACTIVE AGENT COMBINATIONS - The novel active compound combinations of 08-18-2011
20090263517METHOD FOR PRODUCING MARGOSA EXTRACT - The invention relates to a method for producing a margosa extract, an oil from cores and/or seeds of the neem tree being used and the oil being extracted using a carbon dioxide-containing extracting agent. The invention further relates to a margosa extract as is obtained using the method, its use as an agent for pest control and a composition for pest control which contains this extract.10-22-2009
20090169658TOONA SINENSIS EXTRACT FOR SUPPRESSING PROLIFERATION AND INDUCING APOPTOSIS OF OSTEOSARCOMA CELLS - extract for suppressing the proliferation and inducing apoptosis of osteosarcoma, but not normal human osterblasts. The extraction process comprises: extracting 07-02-2009
20110070323PEDICULICIDE COMPOSITIONS - A non-toxic, highly effective composition for the elimination of lice and their eggs is provided. The composition contains natural products, namely plant oils, beside harmless cosmetic additives.03-24-2011
20130011501Anti-Fever Botanical Composition and Uses Thereof - According to at least one aspect of the present invention, a botanical anti-fever composition is provided. In at least one embodiment, the botanical composition comprises a therapeutically effective amount of admixture of parts or extracts of at least one plant species from each of genus 01-10-2013
424731000 Containing or obtained from Ricini (e.g., castor bean, etc.) 4
20110195137DERMO-COSMETIC COMPOSITION FOR PETS - The invention relates to a method of treating the coat of an animal. The method includes the steps of applying a composition to the coat of the animal, diffusing the composition by action of a carrier, storing the active ingredients of the composition by the sebaceous glands of the animal, and gradually releasing the active ingredients from the sebaceous glands. The dermo-cosmetic composition includes a diffusion solvent vehicle that enables, by a simple application to one or more points of the cutaneous surface, a diffusion over the entirety thereof and at the level of the sebaceous glands. The active ingredients, primarily including a complex of essential oils and of polyunsaturated fatty acids, stored in these sebaceous glands can be salted out progressively with the sebum product to the surface of the skin.08-11-2011
20110280970ABSORBABLE PUTTY-LIKE IMPLANTS AND METHODS FOR THEIR USE FOR MECHANICAL HEMOSTASIS OF BONE AND FOR THE TREATMENT OF OSSEOUS DEFECTS - The present invention relates to mechanically hemostatic body-absorbable compositions having a putty-like consistency comprising a finely powdered, carboxylic acid salt, a liquid block copolymer of ethylene oxide and propylene oxide, and a tocopherol.11-17-2011
20120201910Artificial Tears and Therapeutic Uses - The present invention provides ophthalmic compositions, e.g. artificial tears, suitable for treating dry eye syndrome in a human or other mammal suffering there from, e.g. a dog or cat, which comprise a mixture of castor oil with another oil, e.g. a food oil, e.g. olive oil, sesame oil, corn oil etc.08-09-2012
20110052734Transparent Oil Gelling System - The invention relates to a gellant system for a polar oil comprising gellant effective amounts of silica, a sugar fatty acid ester and a long chain polymer. The gellant system of the invention is useful in gelling polar oils to produce transparent or translucent gels useful in topical compositions.03-03-2011
424725100 Pyrolysis product of a plant (e.g., heated to ashes, tar, etc.) 4
20080260867Hair Growth Stimulants and the Manufacturing Method Thereof - A hair growth stimulant having excellent hair growth stimulation and hair growth effects without any side effects, which contains a carbonized pine cone. The inventive hair growth stimulant has an excellent hair growth stimulation effect without causing any side effects or toxicity to the human body, while it can stimulate hair roots to greatly influence the growth of hair so as to prevent hair loss and white hair. Also, it can be provided in the form of creams or ointments having an excellent effect on hair growth stimulation, and thus can considerably shorten a treatment period. It can keep the anagen-stage hair by increasing the blood flow of the scalp, and it consists of a vegetable preparation, and so has no side effects to the human body. In addition, it can be used through smooth application to a head, and thus is easy to use.10-23-2008
20100330209HAIR GROWTH STIMULANTS ADN THE MANUFACTURING METHOD THEREOF - A hair growth stimulant having excellent hair growth stimulation and hair growth effects without any side effects, which contains a carbonized pine cone. The inventive hair growth stimulant has an excellent hair growth stimulation effect without causing any side effects or toxicity to the human body, while it can stimulate hair roots to greatly influence the growth of hair so as to prevent hair loss and white hair. Also, it can be provided in the form of creams or ointments having an excellent effect on hair growth stimulation, and thus can considerably shorten a treatment period. It can keep the anagen-stage hair by increasing the blood flow of the scalp, and it consists of a vegetable preparation, and so has no side effects to the human body. In addition, it can be used through smooth application to a head, and thus is easy to use.12-30-2010
20110038961VAPORIZED LOBELIA PRODUCT AND METHOD OF USE - In one embodiment, a method for 02-17-2011
20130171275USE OF BAMBOO VINEGAR FOR TREATING INFLAMMATION - The preset invention relates to a method for treating inflammation comprising administering a subject in need thereof with a therapeutically effective amount of a composition comprising bamboo vinegar or the phenolic fraction thereof. The method for preparing the phenolic fraction is also provided.07-04-2013
424779000 Containing or obtained from a stem, stalk, branch, or twig, (aka ramus or ramulus) 4
20130040007ANTITUBERCULOSIS COMPOSITION OF BYTTNERIA SPECIES - Active fractions exhibiting anti-tuberculous activity from the plant 02-14-2013
20090263523Enhancer of Cholinesterase Activity - The invention provides an enhancer for cholinesterase. An enhancer comprising Gam Arabic as an active ingredient is useful for preventing and/or treating a decreased cholinesterase activity due to liver damage or inhibition of cholinesterase as a side effect of various agents.10-22-2009
20120308677Pharmaceutical Composition for Preventing and Treating Inflammatory Diseases Containing an Ethyl Acetate Fraction of Dried Extract of Trachelospermi Caulis as an Active Ingredient, and Method for Producing the Fraction - The present invention relates to a pharmaceutical composition for treating and preventing inflammatory diseases comprising an ethyl acetate fraction of dried extract of 12-06-2012
20100291250USE OF AN ACTIVE INGREDIENT THAT IS OBTAINED FROM CYPERUS ESCULENTUS FOR ITS ANTI-AGING CUTANEOUS ACTION - A method of treating cutaneous aging using of at least one active ingredient obtained from 11-18-2010
424751000 Containing or obtained from Nicotiana (e.g., tobacco, etc.) 4
20090142426Aqueous Extract of Tobacco Leaves, Its Uses in the Treatment of Dependence - The invention relates to the use of an aqueous extract of tobacco leaves for the preparation of a medicament for the treatment of dependence, in particular tobacco dependence, and to a sterile injection solution and a kit which can be used for the treatment of dependence, in particular of tobacco.06-04-2009
20080292735REGULATING ALKALOIDS - MPO1 and MPO2 can be regulated for either decreasing or increasing alkaloid levels in plants, in particular in 11-27-2008
20090117212TOBACCO CULTIVAR AOB 176 AND PRODUCTS THEREFROM - The present invention relates to a novel tobacco cultivar designated AOB 176, which has low to intermediate nicotine content. The invention provides seeds of the cultivar AOB 176, plants and parts thereof of the cultivar AOB 176, a tissue culture derived from the cultivar AOB 176, hybrids produced from cultivar AOB 176 and lines derived from cultivar AOB 176, as well as genetically modified forms of the foregoing plants and tissue culture. Also provided are methods of producing cultivar AOB 176 plants, cultivar AOB 176 hybrid plants, and tobacco lines derived from cultivar AOB 176. In addition, products produced from the plants of the present invention are provided.05-07-2009
20110151035Smoking Cessation Lozenge Containing Tobacco Alkaloid And Silver Salt - A smoking cessation aid is in the form of a lozenge containing powdered tobacco and a therapeutically effective amount of a silver salt. In another embodiment, a lozenge contains nicotine and a therapeutically effective amount of a silver salt. In yet another embodiment, a lozenge contains (i) at least one of anatabine, anabasine, and nornicotine, and (ii) a therapeutically effective amount of a silver salt.06-23-2011
424767000 Containing or obtained from Cactaceae (e.g., cactus such as Opuntia, prickly pear, Cereus, Selenicereus, etc.) 3
20090202668Use of a polyphenol in the treatment of the metabolic syndrome and endothelial dysfunction or other vascular sequellae - The invention relates to the use of a polyphenol in the manufacture of a nutriceutical, a food, a food supplement or a medicament for the prophylactic or therapeutic treatment of endothelial dysfunction or the Metabolic Syndrome and other vascular sequellae. The invention further relates to a composition comprising at least one polyphenol and to a method for preparing such composition.08-13-2009
20090285922BAKERY PRODUCTS AND PASTA CAPABLE TO REDUCE BODY WEIGHT AND PLASMA CHOLESTEROL, LIPIDS AND GLUCOSE - The present invention relates to flour-based food products containing Nopal (Opuntia ficus-indica) capable to reduce body weight and plasma LDL cholesterol, lipids and glucose.11-19-2009
20100323045EXTRACT FORMULATION OF OPUNTIA FICUS INDICA - A process for the preparation of an 12-23-2010
424759000 Containing or obtained from Tryptergium 1
20100189825Pharmaceutical composition for treating rheumatism, and method of making same - A pharmaceutical composition for the treatment of rheumatism and a method of preparing it are provided. The composition consists of an alcoholic extract of 1-4 parts by weight 07-29-2010
424748000 Containing or obtained from Commiphora (e.g., myrrh, myrrha, balm of Gilead, etc.) 1
20120237621Treatment of Menopausal Symptoms as Novel Indication for Myrrh - A novel medical indication of myrrh, namely the treatment of menopausal symptoms, is disclosed. Furthermore, pharmaceutical preparation in vaginal dosage form for the treatment of menopausal symptoms, a method for preparing a pharmaceutical preparation against menopausal symptoms, and a method for treating the human or animal body with myrrh to relieve menopausal symptoms are disclosed.09-20-2012
Entries
DocumentTitleDate
20090317494Herbal composition containing COX-2 and its manufacturing method - A herbal composition, containing natural COX-2, includes a powder of Labiatae plant, wherein the herbal composition is prepared by a method including the steps of dehydrating the Labiatae plant and grinding the dried Labiatae plant into a powdered form. The herbal composition is used for treatment of a disease including Nephritis, Lymphoma and colorectal cancer, Acute, chronic, and bile-reflux cholecystitis, and aphonia. The herbal composition is formed as an internal treatment having an administrative form selected from the group consisting of capsule, powder, solution, and syrup. The herbal composition is formed as an external treatment by mixing the powdered Labiatae plant with “Vaseline”.12-24-2009
20090123573ADMIXTURE OF EXTRACTS OF PLANTS OF THE GENUS ROSMARINUS AND CAROTENOIDS FOR TREATING CUTANEOUS SYMPTOMS OF AGING - Intimate admixtures of at least one carotenoid and at least one extract of at least one plant of the genus 05-14-2009
20090123572Method and Pharmaceutical Composition for Treating Psoriasis, Squamous Cell Carcinoma and/or Parakeratosis by Inhibiting Expression of Squamous Cell Carcinoma-Related Antigen - In a first aspect thereof, the present invention provides a method for treatment and/or prevention of a disease selected from the group consisting of psoriasis and squamous cell carcinoma by inhibiting the expression of squamous cell carcinoma antigen (SCCA) by cells. In another aspect thereof, the present invention provides a method for screening for substances that inhibit epidermal parakeratosis, wherein the activity of a candidate substance that inhibits cysteine protease inhibitory activity possessed by squamous cell carcinoma antigen 1 (SCCA-1) is used as an indicator.05-14-2009
20110206785EXTRACT OF POLYGONUM MULTIFLORUM THUNB. EX MURRAY VAR. HYPOLEUCUM AND COMPOSITIONS FOR IMPROVING METABOLIC SYNDROME - An extract of 08-25-2011
20080260866Method for decreasing inflammation and stress in a mammal - The present invention is directed to a method for decreasing inflammation and stress in a mammal comprising; administration to a mammal a composition comprising a glucose anti-metabolite; and wherein said composition comprises amounts of the glucose anti-metabolite sufficient to lower a level of a C-reactive protein in the blood of the mammal subsequent to administration of the glucose anti-metabolite.10-23-2008
20090191286Binding and Rinse-Off of Quaternary Ammonium Compounds for Cosmetic and Personal Care Applications - The disclosed composition and method includes the use of non-polar unsaponifiable material and polar hydrophilic salts in conjunction with quaternary ammonium compounds to provide hair treatment preparations for cosmetic and personal care applications. Disclosed features and specifications may be variously controlled, adapted or otherwise optionally modified to improve substantivity and/or rinse-off characteristics. Exemplary embodiments of the present invention generally provide hair conditioners, shampoos, straighteners, permanent waves, color-fast dyes, non-color-fast dyes, and repair treatments with jojoba hydrolysates in combination with Quaternium 80 for increased substantivity and superior wash/rinse-off benefits.07-30-2009
20090304824Rapid-Melt Compositions, Methods of Making Same and Methods of Using Same - A novel rapid-melt composition, including methods of making the same, and methods of using the same for the delivery of prophylactic and therapeutic active materials to a mammal. The rapid-melt compositions are formed by molding or compression, with an additional heating step being preferred.12-10-2009
20120183633COMPOSITIONS AND FUNCTIONAL FOODS FOR TREATING AND PREVENTING OBESITY USING POLYGONUM CUSPIDATUM BUTANOL FRACTION AND ETHYL ACETATE FRACTION - The present invention relates to the obesity-curative or obesity-preventive effect of a 07-19-2012
20120183632PHARMACEUTICAL COMPOSITION COMPRISING AN EXTRACT OF PSEUDOLYSIMACHION LONGIFOLIUM AND THE CATALPOL DERIVATIVES ISOLATED THEREFROM HAVING ANTIINFLAMMATORY, ANTIALLERGIC AND ANTIASTHMATIC ACTIVITY - The present invention relates to a composition comprising an extract of 07-19-2012
20120183631INGREDIENT EXTRACTED FROM POUZOLZIA ZEYLANICA (L.) BENN AND ITS ANTI-ACNE FORMULA - An ingredient extracted from 07-19-2012
20100119628Anti-aging cosmetic composition - The present invention relates to an anti-aging cosmetic composition, and more particularly, the present invention relates to an anti-aging cosmetic composition containing 05-13-2010
20100119627SPECIAL EXTRACT AND USE THEREOF FOR INHIBITING THE DEGRADATION OF CYCLIC GUANOSINE MONOPHOSPHATE (cGMP) - A process for the preparation of an extract from a plant of the Turneraceae family, comprising the steps of: 05-13-2010
20090053332Compositions for diabetes treatment and prophylaxis - Gurmarin containing compositions are useful for modulation of glucose metabolism and the treatment of diabetes. Glucose metabolism in a human patient is regulated by isolated gurmarin-containing dosage forms that optionally contain a non-metabolizable polysaccharide such as the exudate of 02-26-2009
20100074975Pharmaceutical composition for the prevention and treatment of liver disease comprising a lonicera caerulea L. Var. Edulis extract - Disclosed herein is a pharmaceutical composition having preventative and therapeutic effects on liver diseases, comprising an extract from 03-25-2010
20120244234NIGELLA EXTRACTS FOR THE TREATMENT OF SYMPTOMS CONNECTED TO IMPAIRED OR IMBALANCED NEUROTRANSMISSION - The present invention relates to the use of 09-27-2012
20090304825ESTROGENIC EXTRACTS FOR USE IN TREATING VAGINAL AND VULVAR ATROPHY - Estrogenic extracts of 12-10-2009
20090186101Use of Elderberry Extract - The present invention relates to the field of viral therapy. More specifically, the present invention relates to the use of elderberry extract in the preparation of a pharmaceutical formulation for the treatment of an influenza viral infection. It also relates to a novel method of treatment of the avian flu virus, through the administration of elderberry extract.07-23-2009
20130040001METHOD OF PROCESSING ANIMAL SKIN - The present invention provides a method of processing animal skin, comprising the steps of: 1) providing dry animal skin containing 7-38 wt % water; 2) rehydrating and softening the said dry animal skin, and obtaining softened wet skin; 3) mixing the said softened wet skin with water, and grinding the mixture to a slurry; 4) obtaining a solid product through a crosslink of collagen proteins in the said slurry; wherein, rehydrating the said dry animal skin is performed through soaking the dry animal skin in 0-55° C. water till the animal skin contains 40-50 wt % water; and softening the said dry animal skin comprises a step of heating the rehydrated dry animal skin.02-14-2013
20120263805Detergent, Cleaning Agent or Disinfectant Containing Hydrolyzates Made of Plant Extracts - The invention relates to a detergent, cleaning agent or disinfectant containing at least one plant hydrolyzate, in particular selected from the group including 10-18-2012
20130209588AGAVE SYRUP EXTRACT HAVING ANTICANCER ACTIVITY - The present invention comprises an 08-15-2013
20130209587METHODS FOR ADMINISTERING TUBE FEED FORMULATIONS - Nutritional compositions that mimic whole foods and methods of using the nutritional compositions are provided. The nutritional compositions may include an increased number and variety of fruits and vegetables, an increased variety of macronutrient sources and an increased amount of other components that are found in whole foods. Methods of administering such nutritional compositions to patients in need of same are also provided. The methods may include administering tube feed formulations to a patient at typical meal times such as, for example, breakfast, lunch and dinner.08-15-2013
20100104670USE OF CHITOSANS FOR THE TREATMENT OF NAIL INFLAMMATORY DISEASES - Chitosan-based nail formulations are useful to treat nail inflammatory diseases like psoriasis, atopic dermatitis and 04-29-2010
20100104669Method for preparing an aqueous solution containing triterpenic acid, aqueous solution containing triterpenic acid, and use thereof - A method for preparing an aqueous solution containing triterpenic acid, an aqueous solution containing triterpenic acid, and use thereof, includes preparation of a basic aqueous solution containing triterpenic acid and reduction of the pH of the basic aqueous solution containing triterpenic acid by adding an acidic aqueous solution in the presence of a stabilizing additive. The system may also provide an aqueous physiological solution of a plant extract containing triterpenic acid, a method for preparing same, and use thereof for therapeutic purposes that includes aqueous physiological solutions rich in triterpenic acid which includes pharmacologically effective amounts of triterpenic acids.04-29-2010
20100104668NUTRITIONAL SUPPLEMENT FOR HONEYBEES - A nutritional supplement for honeybees includes plant material chosen from a group comprised of plants known to provide nutrients to the honeybees, a beverage brewed from the plant material and a sugar base upon which the beverage is applied where, when the beverage has dried, the nutritional supplement is formed and can be distributed to supplement a normal honeybee feeding thereby providing a more balanced diet that at least in part helps to strengthen immune systems of the honeybees. The group includes plants known to, at least in part, stimulate a queen honeybee to lay eggs, stimulate hygienic behavior in a honeybee colony, provide a preventive maintenance against disease treat and reduce bacteria, fungus and viruses treat and reduce honeybee dysentery, reduce pests in a honeybee colony, such as tracheal and varroa mite and treat and reduce Deformed Wing Virus in a honeybee colony.04-29-2010
20100040705PEST REPELLENT - A pest repellent is disclosed having long lasting and high repelling efficacy against sanitary insects such as mosquitoes and which is highly harmless to humans. In at lease one embodiment, the pest repellent contains copaiba oil and/or an extract thereof as well as DEET and/or bisabolol.02-18-2010
20100040704Composition and method for weight reduction - Disclosed is a composition and method for facilitating weight loss in individuals. The composition is a physiologically effective amount of the herbal substance 02-18-2010
20100040707INGESTIBLE COMPOSITIONS CONTAINING EXTRACTS - The present invention relates to ingestible compositions containing 02-18-2010
20130028993Composition and Manufacturing Processes of a Toxicity Free Botanical Drug for Curative Treatment of Chronic Diseases - This invention discloses composition and manufacturing processes of a toxicity free botanical drug formulation for curative treatment of chronic diseases. It is manufactured from plants 01-31-2013
20130028992Herbal-Based Solution for Treating Symptoms of Nasal Conditions - An herbal-based solution includes a first amount of wasabi comprising at least an allyl isothiocyanate component, and a second amount of saline solution. The saline solution and the organic material are combined to substantially dilute the wasabi in the saline solution to produce the herbal-based solution. The herbal-based solution further has anti-inflammatory, anti-microbial and anti-coagulative properties. The wasabi may include 01-31-2013
20130028991DIETARY SUPPLEMENT FOR USE IN A WEIGHT LOSS PROGRAM - This invention relates to a dietary supplement for use in a weight loss program, which alleviates insulin resistance in the presence of the metabolic syndrome. The dietary supplement includes, in combination, berberine, banaba leaf extract, and inositol. Also provided is a method of treatment in a weight loss program.01-31-2013
20130028994POMEGRANATE EXTRACT HAVING A HIGH ELLAGIC ACID CONTENT, AND USE OF THE POMEGRANATE EXTRACT - A pomegranate pulp extract is disclosed. The pomegranate pulp extract is effective in relieving women's menopausal symptoms, anxiety disorders, depression or attention deficit disorders due to the presence of a large amount of ellagic acid. Further disclosed is a method for further improving the relieving effect of the pomegranate extract on women's menopausal symptoms, anxiety disorders, depression or attention deficit disorders. The method includes increasing the content of ellagic acid in the pomegranate extract.01-31-2013
20100068310EXTERNAL COMPOSITION FOR SKIN CONTAINING SCROPHULARIA BUERGERIANA MIQ. EXTRACT AND THE USE THEREOF FOR THE SKIN MOISTURIZING COSMETICS - Disclosed herein is a skin external composition for alleviating dry skin symptoms, which contains an extract of 03-18-2010
20090317493Trehalose-containing topical drying composition and method of using same - A topical drying composition is providing containing trehalose as the effective moisture (sweat) removing ingredient. The composition may be used in aqueous form or preferably as a cream and in addition to trehalose it contains several ingredients such as sorbitan monolaurate, polysorbitan, a moisturizer, a thickener, a softener, an antibacterial agent and a pH adjusting component to adjust the pH of the composition between about 5.5 to about 7.5. Sterilized water is used as the carrier for the composition.12-24-2009
20110003017Method for Preparation of Extract from Angelica Gigas Nakai and Composition Containing the Extract - Disclosed is 01-06-2011
20090304827Combinations of Ingredients Having Synergistic Anti-Inflammatory Effects - Nutritional supplement compositions comprising selected herbs and/or herbal constituents thereof that provide synergistic anti-inflammatory effects are disclosed.12-10-2009
20090304823NUTRITIONAL COMPOSITIONS FOR PROMOTION OF BONE GROWTH AND MAINTENANCE OF BONE HEALTH AND METHODS REGARDING SAME - Compositions and methods for maintenance of bone health or prevention, alleviation and/or treatment of bone disorders are presented. The present invention also provides the manufacture of a nutritional product, a supplement or a medicament for promoting bone growth or for the maintenance of bone health and methods regarding same. In an embodiment, the present invention provides a composition comprising an active ingredient having an effective amount of a plant or plant extract containing at least one phytochemical having the ability to induce bone morphogenic protein expression.12-10-2009
20090304822Extract of Polygonum multiflorum Thunb. ex Murray var. hypoleucum and compositions for improving metabolic syndrome - An extract of 12-10-2009
20090041868Binding and Rinse-Off of Quaternary Ammonium Compounds for Cosmetic and Personal Care Applications - The disclosed composition and method includes the use of non-polar unsaponifiable material and polar hydrophilic salts in conjunction with quaternary ammonium compounds to provide hair treatment preparations for cosmetic and personal care applications. Disclosed features and specifications may be variously controlled, adapted or otherwise optionally modified to improve substantivity and/or rinse-off characteristics. Exemplary embodiments of the present invention generally provide hair conditioners, shampoos, straighteners, permanent waves, color-fast dyes, non-color-fast dyes, and repair treatments with jojoba hydrolysates in combination with Quaternium 80 for increased substantivity and superior wash/rinse-off benefits.02-12-2009
20090041866ABNORMAL PROTEIN REMOVING COMPOSITION - It is an object of the present invention to efficiently remove abnormal protein produced in living tissues, especially skin, due to exposure to UV light, etc.02-12-2009
20090041865Extract of the Family Dioscoreaceae and Composition for Preventing or Treating Peripheral Neuropathy Comprising the Same - An extract of the family Dioscoreaceae useful for preventing or treating the peripheral neuropathy; and a pharmaceutical composition or food composition comprising the extract are provided. In addition, a pharmaceutical composition or food composition useful for preventing or treating the peripheral neuropathy comprising a compound isolated from the extract of the family Dioscoreaceae is provided.02-12-2009
20090041864Apparatus and Method for Cellular Extract Enhancement - An apparatus 02-12-2009
20110008472ANTI-METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS AGENT AND ANTI-VANCOMYCIN-RESISTANT ENTEROCOCCUS AGENT - An anti-methicillin-resistant 01-13-2011
20130071497Formulations and Methods for Preventing Eyebrow Hair Loss - Compositions comprising from about 0.5 to about 40 percent by weight of black cohosh extract, from about 0.5 to about 20 percent by weight of nonionic surfactant, and from about to 40 about 99 percent by weight of hydroxylated solvent are effective in reducing and preventing eyebrow hair loss in patients undergoing chemotherapy.03-21-2013
20130071498Insecticidal Compositions and Uses Thereof - The present invention provides compositions and methods for controlling plant pests. In particular, the present invention provides plant extracts with insecticidal activity.03-21-2013
20090092686PROCESS FOR THE RECOVERY OF A PHYTOLIPID COMPOSITION - Disclosed is a process for the recovery of a phytolipid composition from a vegetable oil by-product. The phytolipid composition produced comprises squalene, phytosterols, mixed tocopherols and tocotrieneols, and vegetable wax and is useful as an emollient. The phytochemical composition may be applied directly to the skin to provide emolliency. Alternatively, the phytolipid composition may be formulated in various aqueous or anhydrous cosmetic compositions such as creams, lotions, gels, ointments, lip balms, sticks, or pencils for treatment of the skin and lips. The phytolipid composition also may be incorporated into foods, beverages, and nutraceuticals to provide health benefits.04-09-2009
20130059018PHYTOCANNABINOIDS IN THE TREATMENT OF CANCER - This invention relates to the use of phytocannabinoids, either in an isolated form or in the form of a botanical drug substance (BDS) in the treatment of cancer. Preferably the cancer to be treated is cancer of the prostate, cancer of the breast or cancer of the colon.03-07-2013
20120189719SCHISANDRAE FRUCTUS EXTRACTS FOR INHIBITION OR PREVENTION OF H1N1 INFLUENZA VIRUS INFECTION AND ITS APPLICATION THEREOF - Disclosed are an Schisandrae fructus extract for inhibition or prevention of influenza and its application, wherein the Schisandrae fructus extract is obtained by water, methanol, or ethanol extraction process and the extract comprises compounds such as schisandrone, benzoylgomisin P, wulignan A1, epigomisin O, epiwulignan A1, and tigloylgomisin P. The extracts and purified compounds of Schisandrae fructus has anti-influenza virus H1N1 and H1N1-TR (a Tamiflu drug resistant virus strain) activities, therefore the extracts and the purified compounds of Schisandrae fructus can be applied as an inhitibory agent of a pharmaceutical composition for treatment or prevention agent for influenza infection.07-26-2012
20090280196CISSUS QUADRANGULARIS PLANT EXTRACTS FOR TREATING OSTEOPOROSIS AND THE EXTRACTION PROCESS THEREOF - The invention relates to compositions and methods for preventing, treating, or managing osteoporosis or conditions which are characterized by increased bone resorption, comprising administration of a prophylactically and therapeutically effective amount of 11-12-2009
20090269423Foot-bath Agent of Chinese Herbal Medicine for Regulating Blood pressure and Improving Sleep Quality - The present invention relates to a foot-bath agent of Chinese herbal medicine for regulating blood pressure and improving sleep quality, and the components of the formula thereof are as follows: fructus leonuri 20-25%, semen ziziphi spinosae 15-20%, calcined magnetitum 17-22%, spica prunellae 15-20%, ligusticum chuanxiong hort 18-23%, borneolum 0.7-1.2%; provided that, after the final product is prepared using the above raw materials and the blending ratios thereof, the sum of all components should be 100% by weight. The foot-bath agent prepared has advantages including an efficacious and healthy method thereof being highly consistent with healthy living habits of people, an effective regulation of blood pressure and improvement of sleep quality, no allergy and less side effects to human body, and thus obviously is worthy to be popularized and has market prospect.10-29-2009
20090269424Peripheral blood flow-improving composition - The present invention provides a composition that can effectively improve peripheral blood flow to thereby ameliorate cold sensation, numbness, pains and other skin symptoms, as well as frostbites, chilblains and chaps and other skin disorders associated with disturbed peripheral blood flow. This composition has no side effects. Specifically, the peripheral blood flow-improving composition contains, as an active ingredient, a extract of a plant of the genus 10-29-2009
20130064905Method for Enhancing the Growth and Fullness of Hair - New fibroblast growth factor receptor 1 (FGFR1) inhibitors have been identified which are useful for promoting the retention and/or growth of keratin fibers, such as hair of the scalp, hair of the face (moustache, beard, etc.), eyebrows, eyelashes, and the like. The FGFR1 inhibitors may be formulated in effective amounts in a variety of cosmetic and personal care products.03-14-2013
20130064907COMBINATIONS OF ANTIFUNGAL COMPOUNDS AND TEA TREE OIL - There is disclosed a method for treating a plant infection caused by a fungus of the class ascomycetes, comprising applying to the plant a combination of tea tree oil (TTO) and a synthetic fungicidal compound. Other embodiments are also disclosed.03-14-2013
20130064906HERBAL SKIN CARE COMPOSITION - A topical skin care composition containing an extract solution of 03-14-2013
20110020476Composition based on vegetal extracts of ajuga reptans for preventing hair loss, stimulating the growth of hair, regulating the production of sebum - The present invention relates to preparations based on vegetal extracts of 01-27-2011
20090238900NOVEL ANTI-DIABETIC HERBAL COMPOSITION, METHOD FOR PREPARING THE SAME AND USE THEREOF - Disclosed is an herbal composition for the treatment of Type II diabetes and their associated secondary complications in humans, wherein said composition comprising extract of roots of 09-24-2009
20090238899METHOD FOR RAPID IDENTIFICATION OF PHARMACOLOGICALLY ACTIVE CHEMICAL ENTITIES ASSOCIATED WITH THE EFFICACY OF ETHNOBOTANICAL SUBSTANCES - The method includes the steps of performing in-vitro liver, intestinal and/or expressed enzyme assays with selected ethnobotanical substances, for both humans and a variety of animal species, to produce an array of resulting chemical entities, such as metabolites, for the human and the animals. Comparisons are then made between the chemical entities from the human in-vitro studies and the animal in-vitro studies to determine the closest match. The animal with the closest match is then used for an in-vivo study. If a match is present between the animal in-vivo results and the human in-vitro results, the matched chemical entity is isolated or synthesized and then further tested to determine the suitability of the matched chemical entity as a treatment drug.09-24-2009
20090232911Use of sericin for improving feeling in use of denture - The purpose is to prevent, ameliorate or relieve various conditions induced in the dried oral cavity or to improve the stability of a denture during use. A solution for treating a denture or a denture stabilizer comprising sericin can be used.09-17-2009
20090263509ANTIBACTERIAL AGENT AND ANTIBACTERIAL COMPOSITION - The problems to be solved by the invention are to provide antibacterial agents originated from natural products that are safe for regular use with potent antibacterial activity, and antibacterial compositions containing said antibacterial agents. Antibacterial agents containing Eysenhardtia adenostylis extract or isoflavan compounds are a solution to the problem. Also antibacterial agents containing Eysenhardtia adenostylis extract or isoflavan compounds as active ingredients. The antibacterial agents can be applied to products such as cosmetics, including quasi-drugs, pharmaceuticals and foods. Further, antibacterial compositions containing these antibacterial agents, Eysenhardtia adenostylis extract or isoflavan compounds, and other compositions such as cosmetics, including quasi-drugs, pharmaceuticals and foods.10-22-2009
20090317495COMPOSITION COMPRISING TRACHELOSPERMI CAULIS AND PYROLA JAPONICA EXTRACTS FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY DISEASES - The present invention relates to a pharmaceutical composition for the prevention and treatment of inflammatory diseases comprising a mixture of herbal extracts of 12-24-2009
20090017142Essential Oils Inhibit Mold on Wood - Methods of treating wood lumber to inhibit growth of mold fungi by surface treating the wood lumber with an essential oil, diluted or undiluted, being geranium Egyptian, thyme, dill weed or rosemary. Various surface treatments include dipping, spraying, brushing and vapor exposure.01-15-2009
20120237619COMBRETUM LAURIFOLIUM MART. EXTRACT AND METHODS OF EXTRACTING AND USING SUCH EXTRACT - A method of inhibiting COX-2, inhibiting NF-Kappa B activation, treating inflammation, or treating cancer may comprise administering a therapeutically effective amount of an extract of 09-20-2012
20090061027Composition For The Prevention and Treatment Of Common Cold Diseases - The invention relates to the use of Cistus for producing a composition for the prophylaxis and/or treatment of common cold diseases. In particular, the composition can be used for the prophylaxis and/or treatment of the symptoms of a head cold.03-05-2009
20090142420Cosmetic Composition with Anti-Free Radical Activity - A cosmetic composition has an association of at least three of the following substances with anti-free radical activity, selected from:06-04-2009
20100297267Compositions for diabetes treatment and prophylaxis - Gurmarin containing compositions are useful for modulation of glucose metabolism and the treatment of diabetes. Glucose metabolism in a human patient is regulated by isolated gurmarin-containing dosage forms that optionally contain a non-metabolizable polysaccharide such as the exudate of 11-25-2010
20100291241METHOD OF PRODUCTION OF EXTRACT DERIVED FROM Swinglea Glutinosa LEAVES - The invention of the present Application provides a standardized method to obtain an extract and the extract from leaves of 11-18-2010
20090130234Composition for the Treatment of Diabetic Periodontitis - The invention refers to the use of an extract of a part of a 05-21-2009
20090041867ESTROGENIC EXTRACTS OF LIGUSTRUM LUCIDUM AIT. OF THE OLEACEAE FAMILY AND USES THEREOF - Extracts of various species of the Moraceae family have estrogenic properties. For example, aqueous and ethanolic extracts of 02-12-2009
20100173022COMPOSITION FOR THE TREATMENT OF DIABETES MELLITUS AND METABOLIC SYNDROME - The invention relates to the field of pharmacology. More specifically, the invention relates to a composition for the treatment of diabetes mellitus and/or the metabolic syndrome. Even more specifically, the invention relates to a herbal composition for treating the same. In one of its embodiments, the invention provides a composition comprising a) an anti hyperglycaemic agent b) an anti inflammatory agent c) an anti hyperlipidemic agent d) an anti oxidant agent e) a gastro-intestinal agent, wherein said activities are provided by parts or extracts of 07-08-2010
20080311228PHARMACEUTICAL COMPOSITION FOR PROTECTING NEURONS COMPRISING EXTRACT OF LITHOSPERMUM ERYTHROTHIZON SIEB. ET. ZUCC OR ACETYLSHIKONIN ISOLATED THEREFROM AS AN EFFECTIVE INGREDIENT - The present invention relates to a pharmaceutical composition for protecting neurons or for preventing and treating ischemic neuronal diseases comprising the extract of 12-18-2008
20100316737HOMEOPATHIC COMPLEX - The present invention is directed to a homeopathic complex for use in the treatment of various diseases or disorders, including use as an anti-infective agent and/or in the regeneration of diseased or damaged tissue. Ideally, the anti-infective homeopathic complex of the invention may comprise a homeopathic tincture or dilutions thereof of Hepar sulphuris calcareum or other similar profiled Calcarea or Sulphur salt or acid, Lachesis muta or other remedy with a similar profile, Mercurius Solubilis or similar mercury containing remedy and Silica or other silica containing compounds.12-16-2010
20110008471SYNERGISTIC ANTIPARASITIC COMPOSITIONS AND SCREENING METHODS - Compositions for treating parasitic infections and methods of using the compositions to treat subjects with parasitic infections are provided. Methods of selecting compositions for use in treating parasitic infections are further provided.01-13-2011
20110280968NATURAL EXTRACT CONTAINING XANTHOHUMOL, METHOD FOR THE PRODUCTION THEREOF AND PRODUCTS PRODUCED THEREFROM - The invention relates to a method for producing an extract containing xanthohumol (XN), which is obtained from toasted cereal products, cereal malt, coffee or cocoa. The XN-content in said extract is in the region of 10 mg/kg-2 g/kg xanthohumol. The use of XN-toasted extracts enables the XN-content of foodstuffs and pharmaceutical products to be increased in a natural manner. This Abstract is not intended to define the invention disclosed in the specification, nor intended to limit the scope of the invention in any way.11-17-2011
20090068292Therapeutic herb cosmetic composition - The current invention discloses an herb composition to treat burn, sun burn, physical injury, dermatitis, or to promote skin stem cell proliferation, increase collagen synthesis, increase epidermal thickness, and increase desquamation of normal skin resulting in smoother, younger looking skin. The composition comprises of herb extract from 03-12-2009
20100189819NEURO-DEGENERATIVE INHIBITOR, NEURO-ENDOCRINE MODULATOR, AND NEURO-CEREBRAL METABOLISM ENHANCER - Neuro-metabolic and endocrine-function regulating/modulating compositions, are disclosed. The compositions of the present invention comprise Selegiline Hydrochloride, Procaine Hydrochloride, Vinpocetine, trimethylglycine, and an ingredient selected from a group consisting of N-nicotinoyl-gamma-aminobutyric acid (N-GABA), niacin, niacinamide, gamma-aminobutyric acid (GABA), and combinations thereof. Methods of using the compositions, compositions, and compositions of the present invention are also disclosed.07-29-2010
20090148543Method for protecting humans against superficial vasodilator flush syndrome, - Methods for protection of a human from SVFS comprise the administration of a flavonoid compound of the basic structures 2-phenyl-4H-1-benzopyran or 2-phenyl-4-keto-1-benzopyran or glycosides thereof, alone or, optionally, together with one or more of an olive kernel extract, a non-bovine sulfated proteoglycan, bitter willow extract, a D-hexosamine sulfate, S-adenosylmethionine, folic acid, vitamin B12 and a serotonin inhibitor. Such treatment prevents, reduces or eliminates SVFS in patients receiving as much as 300-3000 mg/day of niacin therapeutically, whether administered prior to, or along with, an anti-SVFS composition.06-11-2009
20120288574METHOD OF PREVENTING PHOTO-AGING WITH ASHWAGANDHA AND INDIAN GOOSEBERRY - A method of preventing photo-aging and its related causes includes administering a therapeutic composition comprising extracts of the plant species ashwagandha (11-15-2012
20100136144COMPOSITION CONTAINING A QUINOA EXTRACT FOR DERMATOLOGICAL USE - The present invention relates to a composition containing a quinoa grain extract, said extract being a peptidic and osidic extract or a lipidic extract of quinoa grain, said lipid quinoa extract being itself chosen from a group comprising an oil concentrated into its non saponificable fraction, a non saponificable, or a refined oil. The invention also relates to methods for preparing these different extracts and to dermatological or neutraceutic applications of these extracts.06-03-2010
20090098220LIQUID PHARMACEUTICAL PREPARATION COMPRISING FORSKOLIN FOR PROMOTING LEAN BODY MASS - A liquid pharmaceutical preparation comprising forskolin in an amount of about 0.025 mg/ml to about 1 mg/ml of the liquid pharmaceutical preparation for promoting lean body mass in a human subject. Further, an effective amount of the liquid pharmaceutical preparation comprising forskolin is administered subcutaneously in the human subject.04-16-2009
20110038957NOVEL NUTRACEUTICAL COMPOSITIONS CONTAINING STEVIA EXTRACT OR STEVIA EXTRACT CONSTITUENTS AND USES THEREOF - The invention relates to a novel nutraceutical composition containing 02-17-2011
20100136145FORMULATIONS CONTAINING CYNARA SCOLYMUS AND PHASEOLUS VULGARIS EXTRACTS WHICH ARE USEFUL IN THE TREATMENT OF OBESITY06-03-2010
20090104292TOPICAL ARNICA TREATMENT FOR REDUCING BRUISING - A method of preventing post-surgery, post-laser treatment or post-traumatic bruising of the skin comprising applying topically to the affected area of the skin a treatment comprising at least 15% by weight 04-23-2009
20090285914Composition Comprising Hovenia Dulcis Thunb. Extract, Lindera Obtusiloba Blume Extract, or Herbal Mixture Extract Thereof - The present invention relates to a method for treating or preventing fibrosis and improving kidney function comprising administering a 11-19-2009
20090202662TREATMENT OF ERECTILE DYSFUNCTION AND LIBIDO ENHANCEMENT - A process for the production of a substance or composition for the therapeutic or prophylactic treatment of erectile dysfunction or the enhancement of libido in a male human or animal subject comprises the step of formulating the substance or composition from at least one of plant material and an extract of plant material of at least one plant species of the family Geraniaceae.08-13-2009
20100247684SYNERGISTIC PESTICIDE COMPOSITIONS - The present invention relates to compositions that include a combination of one or more pesticides and one or more adjuvants.09-30-2010
20110300240CAJANUS EXTRACTS AND GLUCOSAMINE FOR INFLAMMATORY DISORDERS - The present invention relates to novel compositions comprising 12-08-2011
20110117217METHOD OF USING GUAVA EXTRACT - A method of using guava extract is disclosed that includes administering guava extract to a mammal to inhibit, prevent or alleviate at least one of a headache, nausea, dry mouth, lack of appetite, shakiness, and fatigue. A composition is also disclosed that includes a pharmaceutically acceptable carrier and guava extract.05-19-2011
20090252818Curcuma longa (turmeric) based herbal compound formulations as dietary supplements - Herbal compound formulations using herbs 10-08-2009
20090117210ANDROGRAPHIS PANICULATA EXTRACT - An extract of 05-07-2009
20100028464USE OF SAFFRON AND/OR SAFRANAL AND/OR CROCIN AND/OR PICROCROCIN AND/OR DERIVATIVES THEREOF AS A SATEITY AGENT FOR TREATMENT OF OBESITY - Use of saffron and its active ingredients, such as safranal and/or picrocrocin and/or crocin and/or derivatives thereof, for the production of an active satiation agent for the treatment of problems of overweight.02-04-2010
20110293751Composition for Treatment of Skin - The present invention provides a composition comprising stearidonic acid (or an ester thereof) derived for example from 12-01-2011
20110293752Inhibition of Angiogenesis and Destruction of Angiogenic Vessels with Extracts of Noni Juice (Morinda Citrifolia) - Noni juice and a protein-free, alcohol precipitate of Noni juice inhibited angiogenesis in in vitro human angiogenesis models. When growth medium contained Noni juice at least over the range from about 2.5% to about 33% (by volume), angiogenesis was blocked. Moreover, Noni juice and an ethanol precipitate were able to destroy a pre-existing angiogenic response as well as prevent the development of new vessels. Noni juice was effective in inhibiting the growth of angiogenic vessels from breast cancer explants. It will also be effective in treating cancers and non-cancerous diseases whose response includes an increase in angiogenesis, e.g., retinopathy of prematurity, neovascular glaucoma, diabetic retinopathy, and psoriasis. In an initial experiment, Noni juice was effective in treating lesions associated with psoriasis. The primary antiangiogenic component is believed to be a carbohydrate with a molecular weight less than about 6000 Daltons. In an initial experiment, oral administration of Noni juice appeared to adversely affect the antiangiogenic component(s) in the juice.12-01-2011
20090297637Estrogenic Extracts of Anemarrhena Asphodeloides Bge. from the Liliaceae Family and Uses Thereof - Estrogenic extracts of 12-03-2009
20080274213Drug for Ameliorating Male Climacteric Disorders - It is intended to provide a highly safe pharmaceutical drug or food that inhibits reduction in blood testosterone level and prevents or ameliorates symptoms and so on associated with male climacteric disorders. The present invention provides a drug for inhibiting reduction in blood testosterone level and a drug for ameliorating male climacteric disorders comprising a plant belonging to the genus 11-06-2008
20100034906STEAM DISTILLATION OF CATMINT PLANTS - This invention provides processes for improved recovery of essential oil from the catmint (catnip) plant 02-11-2010
20100034903SHINYLEAF YELLOWHORN EXTRACT, METHODS FOR EXTRACTION AND USES THEREOF - An extract of 02-11-2010
20090297638ESTROGENIC EXTRACTS OF Anemarrhena asphodeloides Bge. from the Liliaceae Family and USES THEREOF - Estrogenic extracts of 12-03-2009
20110217391MATRIX METALLOPROTEASE (MMP) PRODUCTION INHIBITOR - It is an object of the present invention to provide a method for inhibiting the production of matrix metalloprotease (MMP), wherein skin aging is suppressed and a highly stable and safe component from plants is used. The present invention provides a method for inhibiting the production of matrix metalloprotease (MMP), which comprises administering a 09-08-2011
20100112097PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING CANCER AND HEALTH FOOD CONTAINING THE SAME FOR PREVENTING AND TREATING CANCER - A pharmaceutical composition for treating and preventing cancer, and health food for ameliorating and preventing cancer containing the pharmaceutical composition are provided. The pharmaceutical composition includes 05-06-2010
20110195135ANTI-AVIAN INFLUENZA VIRUS AGENT, AND PRODUCT CONTAINING ANTI-AVIAN INFLUENZA VIRUS AGENT - An anti-avian influenza virus agent containing, as an active ingredient, a component obtained when a guava extract extracted from a guava with an extraction solvent consisting primarily of at least one of water and a hydrophilic organic solvent is subjected to fractionation by HPLC under specific conditions. The specific conditions include the use of an ODS column, the use of a water-methanol mixture having a methanol concentration of 20% as a mobile phase during a period until 15 minutes after applying the guava extract to the column, and the use of a water-methanol mixture having a methanol concentration of 40% as a mobile phase during a subsequent period of 15 to 30 minutes. Alternatively, the specific conditions further include the use of a water-methanol mixture having a methanol concentration of 60% as a mobile phase during a period of 30 to 45 minutes after applying the guava extract to the column. The component contained in the anti-avian influenza virus agent is eluted from the column in a period until 20 minutes after applying the guava extract to the column or in a subsequent period of 20 to 35 minutes.08-11-2011
20090148544Cosmetic composition containing an extract from lotus and method of cosmetic care using said composition - The invention relates to a cosmetic composition containing at least one extract from at least one part of the Sacred Lotus plant (06-11-2009
20090142421ACTIVE FRACTION OF A POLAR SOLVENT EXTRACT FROM THE LATEX OF EUPHORBIACEAE PLANTS - The present invention generally refers to an active fraction of an extract of the latex of plants from the family Euphorbiaceae in a polar solvent, as well as of one or more compounds contained therein, as well as the use of said fraction and/or said compounds, particularly in the treatment of cancer. The invention also refers to compositions comprising said active fraction and/or said compounds, as well as their use for the treatment of diseases concerning cell proliferation/angiogenesis, particularly cancer.06-04-2009
20110171326Pharmaceutical material for psoriasis treatment - One embodiment of a pharmaceutical material for psoriasis treatment includes a liquid preparation by extracting herbs selected from the group consisting of 07-14-2011
20090130235METHOD FOR MARKETING VIBRATION MEDICINE PRODUCTS - It is disclosed a method for marketing vibration medicine products. The method includes getting an original liquid vibration medicine product, producing a powder vibration medicine product, providing that powder vibration medicine product for blending inside a food or drink entity to get a new entity, and marketing the new entity as an improved first entity. The original vibration medicine product includes essences, and is marketed as having properties associated with the essences. The production of the second product is done using the original vibration medicine product and an acceptable food carrier as raw materials. Consequently, the second product has some presence of the original essences. The second entity is improved over the first entity in its association with the first vibration medicine product.05-21-2009
20090311350COMPOSITIONS FOR ALLEVIATING INFLAMMATION AND OXIDATIVE STRESS IN A MAMMAL - An antioxidant-promoting composition that increases antioxidant defense potential in a subject is disclosed comprising 12-17-2009
20090311349METHOD OF QUANTIFICATION OF MULTIPLE BIOACTIVES FROM BOTANICAL COMPOSITIONS - A method of quantifying multiple bioactive compounds is disclosed.12-17-2009
20120164243Compositions and Methods for Improving Mitochondrial Function and Treating Neurodegenerative Diseases and Cognitive Disorders - Provided are compositions comprising compounds or precursors to compounds which may be used for a variety of therapeutic applications including, for example, treating and/or preventing a disease or disorder related to reduced or inadequate mitochondrial activity, including aging or stress, diabetes, obesity, and neurodegenerative diseases. The compounds relate generally to urolithins and precursors thereof, including but not limited to ellagitannins and urolithin A. In certain embodiments the compositions are presented in or as food products or nutritional supplements. These same compounds and compositions can also be used advantageously in generally healthy individuals to increase or maintain metabolic rate, decrease percent body fat, increase or maintain muscle mass, manage body weight, improve or maintain mental performance (including memory), improve or maintain muscle performance, improve or maintain mood, and manage stress.06-28-2012
20090087500GUAVA LEAF EXTRACT POWDER AND METHOD FOR PRODUCTION THEREOF - To provide a guava leaf extract powder which exhibits less deterioration in quality and functions after storage of the solution thereof for a long period of time.04-02-2009
20100080862COMPOSITIONS AND FOODS FOR IMPROVING LIPID METABOLISM - It is intended to provide compositions and foods for use in the treatment, prophylaxis, or amelioration of diseases or symptoms which can be treated, prevented or ameliorated by activating PPAR, in particular, insulin resistant diabetes and hyperlipidemia. Namely, medicinal compositions usable in treating, preventing or improving diseases or symptoms which can be treated, prevented or ameliorated by activation PPAR which contain humulones, isohumulones or lupulones or pharmaceutically acceptable salts or solvates thereof.04-01-2010
20110171327GUAVA PULP COMPOSITION - The present invention discloses a guava pulp (also referred to as pulp composition) of a particle size not greater than 0.25 mm which does not contain seeds and peels from the guava and has a lycopene concentration which is 1 to 2 folds higher than the lycopene concentration in the guavas from which the pulp is obtained. The invention further discloses uses of the pulp composition as starting material for obtaining guava oleoresin and lycopene, and as antioxidant.07-14-2011
20120107425USE OF RHODIOLA CRENULATA EXTRACT VIA THE TOPICAL ROUTE - The invention relates to the use of a 05-03-2012
20120107424ANTI DENGUE ACTIVITY OF CISSAMPELOS PAREIRA EXTRACTS - The present invention relates to the anti dengue activity of the 05-03-2012
20090263512COMPOSITION COMPRISING XANTHOCERAS SORBIFOLIA EXTRACTS, COMPOUNDS ISOLATED FROM SAME, METHODS FOR PREPARING SAME AND USES THEREOF - This invention provides compositions, methods and process of producing extracts from 10-22-2009
20090263511INSECTICIDAL COMPOSITION - The use of dill oil or a mixture of two or more components thereof as a potentiator for a pesticide, such as an insecticide and in particular a pyrethroid is described, together with compositions containing dill oil, and their use in agriculture and in veterinary applications.10-22-2009
20100098784CAPSULE CONTAINING PLANT PREPARATIONS - The invention relates to a composition containing a lipophilic extract of 04-22-2010
20100098785Composition of Ashwagandha and Indian Gooseberry - A therapeutic composition comprising extracts of the plant species ashwagandha (04-22-2010
20100098786FORMULATION CONTAINING A CARBOXYLIC ACID OR AN ESTER THEREOF - A formulation comprising eicosapentaenoic acid, or an ester thereof, and a triterpene, or an ester thereof, and the use of such a formulation.04-22-2010
20090142422Herbal compositions for the regression of chronic inflammatory skin disorders - Herbal compositions that, when used in an effective amount, are suitable for the regression of chronic inflammatory skin disorders, including eczema, psoriasis and seborrheic dermatitis. The compositions, formulated as ointments, oils and shampoos, are comprised of a non-aqueous extract of 06-04-2009
20100021567Peganine Isolated from Anisotes Trisulcus L. as a Smoking Deterrent and Anorxigenic Agent - This patent concerns the discovery of the effectiveness of an alcoholic total extract of the aerial parts of the plant 01-28-2010
20090142418ANTIVIRAL COMPOSITION COMPRISING ALNUS JAPONICA EXTRACTS - Antiviral compositions including 06-04-2009
20110268821EXTRACTING AN EXTRACT SUBSTANCE FROM A RAW MATERIAL - The present invention relates broadly to the extraction of an extract substance from a raw material. The extract substance may have application in the food, cosmetics, insecticide or other industries. The raw material may be in the form of vegetable or fruit matter or waste. The extract substance is to be in the form of a concentrated food (for humans or animals) or cosmetic including but not limited to aromatic substances.11-03-2011
20090285913Trachelospermi Caulis Extract Composition for the Treatment and Prevention of Inflammatory Diseases - The present invention relates to a pharmaceutical composition for the prevention and treatment of inflammatory diseases comprising The present invention relates to a pharmaceutical composition for the prevention and treatment of inflammatory diseases comprising 11-19-2009
20080206366COSMETIC COMPOSITION COMPRISING EXTRACT FROM MALLOTUS JAPONICUS FOR IMPROVING SKIN WRINKLE - The present invention relates to compositions for inhibiting elastase activity, enhancing collagen biosynthesis and improving skin wrinkle, comprising 08-28-2008
20090274778Compositions Exhibiting Inhibition Of Cyclooxygenase-2 - The invention provides a method of treating diabetes by administering to an individual having diabetes a composition containing a hops extract. In a particular embodiment, an individual having diabetes can be administered a composition comprising a first component selected from the group consisting of alpha acids and beta acids, essential oils, fats and waxed, with the proviso that the first component and second component are not the same compound. The invention additional provides a method of treating diabetes by administering to an individual having diabetes a composition comprising a first component selected from a curcuminoid and a second component selected from an alpha acid and a beta acid.11-05-2009
20090104291WATER-DISPERSIBLE NANOPARTICLE WHICH CONTAINS BLOOD CIRCULATION PROMOTER - It is an object of the present invention to provide a nanoparticle which comprises a blood circulation promoter and a biodegradable polymer, which is safe and excellent in terms of dispersion stability and has high transparency and good absorbability due to its small particle size. The present invention provides a water-dispersible nanoparticle which comprises a blood circulation promoter and a biodegradable polymer.04-23-2009
20090104290ENERGIZING FORMULATION - The present invention relates to a pre-mix and a pharmaceutical composition for oxygenating a subject's tissues, uses and methods of treatment thereof.04-23-2009
20090104289FORMULATION OF ANTIMICROBIAL FILM, COATINGS AND/OR SPRAYS CONTAINING PORTULACA OLERACEA EXTRACT AND FILM PREPARED THEREFROM - An antimicrobial film formulation is prepared by extracting 04-23-2009
20090104288Compositions and methods for inhibiting a honey bee pathogen infection or controlling a hive infestation - The present invention is directed to methods and compositions to prevent or treat a honey bee pathogen infection (e.g., 04-23-2009
20090074891COMBRETUM LAURIFOLIUM MART. EXTRACT AND METHODS OF EXTRACTING AND USING SUCH EXTRACT - A method of inhibiting COX-2, inhibiting NF-Kappa B activation, treating inflammation, or treating cancer may comprise administering a therapeutically effective amount of an extract of 03-19-2009
20090285912Food Supplement and Method for Enhancing Athletic Performance - Food supplements comprising 11-19-2009
20090285911Cynara scolymus extracts, the use thereof and formulations containing them - The present invention relates to the preparation of a 11-19-2009
20090291153Health food, Method for producing the same and dried Product and Extract - Conophylline, contained in leaves of 11-26-2009
20090155392Methods and Systems for Sublingual Guarana Administration - Embodiments of the present invention relate generally to methods and systems for the sublingual and buccal administration of herbal supplements, and more particularly, to the sublingual and buccal administration of Guaraná, which allows for considerably reducing the therapeutic dose, with the additional advantage of increasing the quickness of the beneficial effects.06-18-2009
20090291155Herbal Composition - The present invention relates to a novel herbal composition comprising extract of leaves of 11-26-2009
20090297639Cosmetic treatement method for fighting against skin ageing effects - The present invention relates to a method of cosmetic treatment for combating the effects of skin ageing and to novel cosmetic compositions which are particularly suitable for carrying it out.12-03-2009
20090297636SENSORIC IMPRINTING - The invention concerns a method for exposing an infant to multiple different tastes of food products and stimulating the consumption of e.g. vegetables and fruit later in life.12-03-2009
20080213405Pharmaceutical compositions containing bulbophyllum and their use for treating illnesses - Described are pharmaceutical compositions containing 09-04-2008
20110268822METHODS FOR SYNTHESIZING KOTALANOL AND STEREOISOMERS AND ANALOGUES THEREOF, AND NOVEL COMPOUNDS PRODUCED THEREBY - Compounds having the general formula (I): wherein X is S, Se or NH, and stereoisomers thereof, and de-O-sulfonated analogues of all of the foregoing, but excluding naturally occurring kotalanol and de-O-sulfonated kotalanol, and methods for synthesizing same. The compounds are useful as glycosidase inhibitors, and may be used in the treatment of diabetes. The synthetic compounds may also be used as standards in the calibration or grading of natural or herbal remedies produced from natural sources of glycosidase inhibitors such as kotalanol.11-03-2011
20100062083DERMAL FILM-FORMING LIQUID FORMULATIONS FOR DRUG RELEASE TO SKIN - The present invention is directed to liquid compositions containing chitosan, a chitosan derivative or a physiologically acceptable salt thereof, forming a dermal film after application onto the skin, useful for delivery of actives onto the skin surface and in the stratum corneum.03-11-2010
20100062084Treatment Of Gastrointestinal Diseases - The present invention relates to compositions (including medicaments and nutritional products) for use in the prevention or treatment of gastrointestinal disease. Such compositions comprise a therapeutically effective amount of a less than or equal to 4 kDa soluble fraction derivable from potato juice.03-11-2010
20100143509THERAPEUTIC COMPOSITIONS FROM JAMAICAN BITTER YAM AND METHODS OF MAKING AND USING SAME - The invention relates to therapeutic compositions, in particular to therapeutic compositions made from Jamaican bitter yam that are substantially free of tannins and alkaloids and comprise fiber, and methods of making and using such therapeutic compositions.06-10-2010
20080241281Compositions & methods for activation and inhibition of Staphylococcus aureus biofilm development - Botanical extracts and derivative compositions are described for activating or inhibiting the formation and development of bacterial biofilms. Gymnemic acids and other associated saponins are isolated from botanical extractions of the 10-02-2008
20110206784COMPOSITION FOR THE PREVENTION AND TREATMENT OF POSTMENOPAUSAL SYNDROME CONTAINING EXTRACTS OR FRACTIONS OF ACERIPHYLLUM ROSSII AS AN EFFECTIVE INGREDIENT - The present invention relates to a method for the prevention and treatment of postmenopausal syndrome containing the step of administering a pharmaceutically effective dose of the 08-25-2011
20080233215EXCIPIENT AND AN IMPROVED METHOD FOR MANUFACTURING EXTRACTED, EVAPORATED, GRANULATED BOTANICAL HERB PRODUCT - An excipient and a method for manufacturing concentrated Chinese herbs through using the excipient are provided. The manufacturing method includes the following steps: (a) providing a Chinese herb raw material; (b) obtaining an extract from the Chinese herb raw material; (c) collecting volatile oils in a separate bin, later reintroduced; (d) removing water from the extract, to get a concentrate; and (e) adding an excipient to the concentrate, and then granulating and drying, to get a Chinese herbal preparation, in which the excipient contains a capsule protective agent of 1-99 wt % with respect to the excipient and a decomposed product of starch of 1-99 wt % with respect to the excipient. Therefore, the amount of starch required to be used is reduced and the manufactured concentrated Chinese herbal preparation can be completely dissolved in water.09-25-2008
20100080861COSMETIC OR DERMATOLOGICAL COMPOSITIONS COMPRISING A MIXTURE OF ESSENTIAL OILS, AND ITS USES THEREOF, PARTICULARLY FOR THE CARE OF SENSITIVE OR SENSITIZED SKIN - The present invention relates to cosmetic or dermatological compositions comprising a combination of a cannabis essential oil substantially free of cannabinoids and a helichrysum essential oil, and to their uses thereof, particularly for the care of sensitive or sensitized skin.04-01-2010
20080286386Na+, K+-Atpase Expression in Cervical Dysplasia and Cancer - The present disclosure provides methods of diagnosing cervical dysplasia and cervical cancer by detecting Na11-20-2008
20080286384Topical Wound Care Product Containing Hyssop - A composition for treating wounds having an effective amount of hyssop extract, combined with glycerol, salt, saccharides, and water has been discovered to be effective in promoting healing of wounds.11-20-2008
20080292732Plant and Plant Storage Organ Having Glp-1 Derivative Accumulated Therein and Method of Producing the Same - The present invention is to provide a plant and a plant storage organ thereof in which GLP-1 derivatives are accumulated, and a method of producing them in order to develop a method for ingesting orally GLP-1 derivatives at a low cost and to make use of it in diabetic treatment. A transgenic plant or a plant storage organ thereof in which GLP-1 derivatives are accumulated cleavable with a digestive enzyme is produced by a method comprising: integrating into a vector a linked GLP-1s-DNA which comprises tandem repeated “n” DNAs (“n” being an integer of 3 or more) encoding a GLP-1 derivative consisting of GLP-1 (7-36) or of an amino acid sequence of GLP-1 (7-36) in which one or a few amino acids are deleted, substituted and/or added, and C-terminal consists of Arg or Lys, and having GLP-1 activity; introducing the vector into a plant cell; and redifferentiating the obtained transformant. The transgenic plant and the plant storage organ are useful as a pharmaceutical composition or a food or drink for treating or preventing diabetes.11-27-2008
20090098222Accelerating Agent of Calcium Absorption - The present invention provides an accelerating agent for calcium absorption comprising Gum Arabic, which is daily available while simultaneously taking dietary fiber.04-16-2009
20080241282Sorghum Extract Compositions - Methods and compositions for preventing or treating various diseases or conditions in a patient with an alcohol extractable fraction of 10-02-2008
20080274212Herbal Extract for Renal Disorders - The present invention relates to the use of standardized extract of 11-06-2008
20080268074Cosmetic Compositions and Methods Comprising Rhodiola Rosea - A cosmetic composition comprising a UV-protective amount of at least one rosavin, preferably present in an extract of 10-30-2008
20090181110Compositions from Garcinia as Aromatase Inhibitors for Breast Cancer Chemoprevention and Chemotherapy - Aromatase inhibitors (AIs) are disclosed which are useful in the treatment and prevention of post-menopausal breast cancer. New AIs derived from natural products are disclosed that are evaluated for clinical utility for treating post-menopausal breast cancer and may also act as chemopreventive agents for preventing breast cancer. Several pure compounds demonstrated AI activity using a noncellular, enzyme-based microsomal and a cell-based aromatase assay. Correlations are made between structural classes with levels of aromatase inhibition. The disclosure may be utilized to direct synthetic modification of natural product scaffolds to enhance aromatase inhibition or to standardize botanical dietary supplements for increased aromatase inhibition activity.07-16-2009
20120141610Novel Topical Composition Of Sarracenia Purpurea (Pitcher Plant) - A composition having a pitcher plant component and a fatty acid component, wherein the pitcher plant component is an alcohol extract, the pitcher plant component further comprises a preservative component, the pitcher plant component is prepared through a soak and press technique and prepared through steam distillation, the composition of claim 06-07-2012
20090181112TABLET COMPOSITION CONTAINING KAMPO EXTRACT - Provided is a tablet composition containing Kampo extract having more excellent disintegration and dissolution properties than ever before. The tablet composition containing Kampo extract contains a Kampo extract powder, croscarmellose sodium, and sodium hydrogen carbonate. The Kampo extract powder is preferably at least one extract powder selected from the group consisting of Kakkonto, Kakkontokasenkyushin'i, Shoseiryuto, Tokishakuyakusan, Kamishoyosan, Keishibukuryogan, Hochuekkito, Bofutushosan, Goshajinkigan, Maobushisaishinto, Keishikajutsubuto, Juzentaihoto, Sokeikakketsuto, Shakuyakukanzoto, Keishininjinto, Tokakujokito, Yokukansan, Goreisan, and Eppikajutsuto.07-16-2009
20090181111Saponin And Preservative Compositions For Reduction of Protozoa - The invention is related to methods and compositions for reducing protozoa populations in animals. In an embodiment, the invention includes a method for reducing protozoal populations including administering a first composition comprising an effective amount of saponins to the animal, and administering a second composition comprising an effective amount of a preservative to the animal. In an embodiment, the invention includes a method for killing protozoa comprising contacting protozoa with a composition comprising an effective amount of saponins and an effective amount of ethoxyquin. Other embodiments are included herein.07-16-2009
20120070515Composition Comprising the Extract of Anemarrhena Asphodeloides Bunge or the Compounds Isolated from the Same for Preventing and Treating Lipid Metabolism Disorder - The present invention relates to a composition comprising an extract of 03-22-2012
20120070514AROMATASE INHIBITOR - A substance is disclosed that can inhibit the activity of aromatase (an enzyme capable of converting androgen into estrogen) to thereby effectively treat and/or prevent a sex hormone-dependent disease such as breast cancer occurring in a female person after menopause, as well as a climacteric disorder in a male person and metabolic syndrome caused by the accumulation of a visceral fat. Specifically, a therapeutic and/or prophylactic agent for a sex hormone-dependent disease comprises at least one herbal extract selected from the group consisting of “Kokeiten,” prunella spike, sweet hydrangea leaf, milk thistle, a jasmine tea, “Bokusoku,” “Tencha,” “Karensou,” “Youbaihi,” French maritime pine, betel palm, asparagus, “Rouro,” “Ryoukyou,” rooibos tea, rhubarb, pu-erh tea, green tea, “Ougon,” St. John's wort, licorice, “Senrikou,” wintergreen, “Kashi,” “Yagotou,” polygnum root, barrenwort, guarana, “Ouhi,” Argy's wormwood, sticky rehmannia, Japanese cornel, Asiasarum root, cinnamon, peony root, pine needle and amla fruit.03-22-2012
20090175963ANTIVIRAL COMPOSITION COMPRISING LYCORIS SQUAMIGERA EXTRACTS - Antiviral compositions including 07-09-2009
20090186103Process for obtaining dried plant material - A process for obtaining dried plant material of plants from the Apocynaceae family, also known as Asclepiadaceae family, which contain steroidal glycosides having appetite suppressant activity. Said process covers (after harvesting and removing the roots a comminution step, a holding step of 1-36 hours in which moisture loss is limited, and a drying step.07-23-2009
20090186102HERBAL MEDICINE FOR OSTEOPOROSIS AND RELATED CONDITIONS - A composition derived from six plant materials: ((i) Herba epimedii □□□ (Yin Yang Huo) (ii) Fructus Psoraleae (07-23-2009
20090186100MEDICAMENT FOR ANTI-AGING SKIN CARE AND WOUND HEALING AND USE THEREOF - A composition comprising Semen Lactucae sativae, Fructus oryzae and Resina Boswelliae carterii for prophylaxis or treatment of skin-aging, increasing skin hydration, improving wrinkle; and facilitating wound healing rate and improving wound quality.07-23-2009
20100151058COMPOSITIONS FOR PRODUCING SATIETY - Long term weight loss can be achieved and maintained with a formulation of over-the-counter life-enhancing dietary supplements. One or more supplements stimulate the release of serotonin within the brain and one or more supplements stimulate the release of cholecystokinin into the bloodstream. The combined potentiating effect of these two mechanisms on satiety enables greater weight loss than that previously achieved by the individual mechanisms acting alone. A third weight loss mechanism can be achieved with the addition of phenylethylamine. Even more effective weight loss formulations can be achieved with the addition of a blue-green algae, such as aphanizomenon flos aqua, to provide a longer lasting weight loss mechanism.06-17-2010
20100151059USE OF VITEX AGNUS CASTUS EXTRACTS FOR PREPARING A MEDICAMENT - The present invention relates to the use of fruit extract from 06-17-2010
20130216633Articles and Compositions for Enhancing Sports Scores - Methods and compositions for enhancing the score of an individual in a sport activity are disclosed.08-22-2013
20080317881METHOD FOR SUSTAINABLE TRANSGENE TRANSCRIPTION - The present invention relates to constructs and methods for improving expression of transgenes in plants, animals and humans.12-25-2008
20080317880PLANT ISOFLAVONE AND ISOFLAVANONE O-METHYLTRANSFERASE GENES - The invention provides enzymes that encode O-methyltransferases (OMTs) from 12-25-2008
20090246299FAT COMPOSITION - The present invention relates to fat composition, more specifically relates to 60% to 99.9% by weight of diglyceride containing 0.1 to 89.9% by weight of conjugated linoleic acid; 0.001% to 0.2% by weight of banaba extracts fermented by microorganism such as 10-01-2009
20090246298Viagra - 1. Couch Grass works on the prostate gland to clear it of bacteria. If this bacteria is allowed to build up it could cause arthritis neuralgia, cancer, and neurological, problems. The blood is cleaned by the Magistral Viagra and hormones are activated. Couch Grass is in the carrot family, it is potent. The potency of Couch Grass is 10 to 1 it is 10× more potent than carrots. It is very high in potassium. 10-01-2009
20090208594Cosmetic and dermatological composition for psoriatic skin treatment - Cosmetic and dermatological composition for the treatment of psoriatic skin, comprising 5%-15% quince seeds; 10%-40% natural base cream; and 55%-75% mixture of anti-oxidants, skin softening agents, absorption aids, tissue regenerating and protecting agents, preservatives and thickening agents.08-20-2009
20090208595Extract of plant Dendrobii caulis and preparing process thereof - An extract of plant 08-20-2009
20090208593PHYTO AROMA MICRO-NUTRITHERAPEUTIC COMPOSITIONS IN ORODIETOLOGY - The invention concerns a composition comprising at least a nutrient and at least a phytotherapeutic compound. The composition according to the invention is characterized in that it also comprises at least an essential oil and/or essence and it is in the form of a granule. The invention is used as a complement of a varied and balanced diet for indications such as aging, weight loss, discomfort related to hormonal changes of the pre-menopause and menopause, drainage, digestion, intestinal transit, relaxation, calm, microcirculation, appeasement of the bacterial flora, painful joints, physical and mental fatigue, protection of the immune system, or even whiten teeth and reduce urge to smoke.08-20-2009
20090324753Product and composition for alleviating post-menstrual symptoms - The current invention relates to a natural composition for topical application to skin to alleviate post-menstrual symptoms of cramping, backache, and breast tenderness; and for other aches and pains including Rheumatic, muscular and articular pains; and local treatment such as tendinitises, tennis elbow, benign distorsions, arthritis, osteoarthritis, neuralgia, sciatic nerve, lumbago, back pains, migraine, stiff neck, and insect bites. In one embodiment, the composition of the cream or lotion includes active natural ingredients of Carapa procera and Calotropis procera with shea butter and soy oil. In one embodiment the composition includes, by weight percent, 30% to 80% Butyrospermum parkii (Shea butter); 10% to 30% Glycine poja (soy); 10% to 30% Carapa procera; 3% to 10% Calotropis procera; and 3% to 10% Menthol.12-31-2009
20090324751CHINESE HERB EXTRACT FOR TREATING DEMENTIA AND PREPARATION METHOD THEREOF - The present invention relates to a 12-31-2009
20090324750PHARMACEUTICAL COMPOSITION COMPRISING AN EXTRACT OF PSEUDOLYSIMACHION LONGIFOLIUM AND THE CATALPOL DERIVATIVES ISOLATED THEREFROM HAVING ANTIINFLAMMATORY, ANTIALLERGIC AND ANTIASTHMATIC ACTIVITY - The present invention relates to a composition comprising an extract of 12-31-2009
20130122118METHOD AND APPARATUS FOR TREATING PESTS - A device for treating pests and method for using the same. The device comprises an effective amount of endod. The device can be placed in a body of water wherein the endod treats the pests. Additionally the device can be placed in a pipe whereby a combination of the endod and the mechanical force of the water removes the pests in the pipe.05-16-2013
20130122119PHYLLANTHUS AMARUS COMPOSITIONS AND METHOD OF EXTRACTING SAME - An enriched hydrolyzable tannin blend derived from 05-16-2013
20130122120INSECTICIDAL COMPOSITIONS AND METHODS - The present invention provides compositions that may be an aqueous insecticide containing at least one surfactant, such as for instance, sodium lauryl sulfate, at least one preservative, such as for instance, a potassium salt or sodium chloride, a nutrient source, such as for instance a yeast, an organic acid capable of lowering the pH of the aqueous insecticide, such as for instance citric acid, a fragrance, such as for instance geranium oil, and water. The aqueous insecticide may be designed to more efficiently kill and thereby control populations of species of 05-16-2013
20110223262Method of Enhancing Biological Activity of Plant Extracts - The present invention relates to a method of modulating a selected biological activity of a naturally occurring material having one or more biological activities in an extract of the naturally occurring material, the method comprising incubating the extract in a medium in the presence of an aerobically metabolizing microorganism, under suitable aerobic conditions, for a period of time sufficient to modulate the selected activity with respect to baseline activity of the unincubated extract. The invention also relates to the bioconverted material so prepared, and the use of same in cosmetic or pharmaceutical compositions.09-15-2011
20090022821COMPOSITIONS FROM WAX MYRTLE FOR THE TREATMENT OF CANCER, CARDIOVASCULAR AND INFLAMMATORY DISEASES - The present invention relates to the use of certain novel compositions from wax myrtle (01-22-2009
20090053333TREATMENT OF VEGETATION LIQUORS DERIVED FROM OIL-BEARING FRUIT - The present invention relates to processes for the treatment of liquors derived from oil-bearing fruit, for example from oil palm fruit, and to products therefrom. Typically a process involves removal of undissolved solids, oleaginous parts, colloids and higher weight molecules from the vegetation liquor to give an aqueous fraction containing phytochemicals, for example, flavonoids, phenolic acids and hydroxy acids. Subsequently, pH adjustment and solvent extraction upon said aqueous fraction realise an extract rich in hydroxy acids or phenolic acids or flavonoids or any combination thereof. Applications of the substances subject of this invention are to be found in drinks, edible products, tonics, health supplements, antioxidant additives, cosmetics, soaps, shampoos, detergents, drugs or medicinal products.02-26-2009
20090053331Hands and feet sanitizing system - A sanitizing system is provided which includes an antibacterial liquid composition formulated to sanitize and deodorize the hands, feet, and other areas of the body. The antibacterial liquid composition is adapted to be dispensed from a pump dispenser as a topical spray.02-26-2009
20110142967METHOD OF REDUCING BLOOD CHOLESTEROL AND TRIGLYCERIDE LEVELS USING COMBINATIONS OF VASOPROTECTIVE AGENT - Combinations of vasoprotective agents useful for the treatment of reducing blood cholesterol and triglyceride levels induced by an excess of plasma lipids. The agents include polycosanols, tocotriends and/or lycopene, procyanidole oligomers and vegetable oil rich in insaturated fatty acids.06-16-2011
20110142965SKIN MOISTURIZER AND WASHING FORMULATION - Disclosed is a liquid skin cleansing and moisturizing composition comprising a skin moisturizing agent, a cationic guar gum, an anionic surfactant, a zwitterionic surfactant, and a non-lipid structuring agent, wherein the composition is dermatologically acceptable and formulated as a rinse-off composition.06-16-2011
20090098221Creatine ascorbyl derivatives and methods of use thereof - The present invention provides methods of treating creatine responsive states, such as a neurological disorder (i.e., Huntington's disease, Parkinson's disease, amyotrophic lateral sclerosis, muscular dystrophy, Charcot Marie Tooth syndrome, Alzheimer's disease, or creatine transporter defect) or a skin disorder, by administering a creatine-ascorbyl derivative.04-16-2009
20090004299Methods for Inhibiting a Decline in Learning and/or Memory in Animals - A method for inhibiting a decline in learning and/or memory in an animal comprising maintaining the animal on an antioxidant-fortified diet for a period of at least about 3 years. The diet comprises at least one antioxidant in a total antioxidant amount effective to achieve such inhibition. Suitable antioxidants include vitamin E, vitamin C, α-lipoic acid and antioxidant-containing plant meals. The methods are particularly useful for young adult canines such as dogs.01-01-2009
20090136600METHOD FOR ALLEVIATING CHEMOTHERAPY SIDE EFFECTS USING EXTRACT OF DIOSCOREA SP. - Extract fractions of 05-28-2009
20110142964Increasing athletic performance in humans with ruta chalepensis extract - The present invention relates to increasing the athletic performance of humans, using ruta chalepensis extract as an oral supplement or medicine. Use of the invention provides increased muscle strength, muscle power, endurance, muscle protein content, and/or reduced fatigue following exercise or competition.06-16-2011
20090252817Methods for the treatment or prevention of Diabetes Mellitus and other metabolic imbalances - The invention relates to methods for treatment and prevention of a metabolic imbalance, including diabetes mellitus and other related diseases or disorders, using an extract from a fruit of genus 10-08-2009
20090238901Method for Treatment of Constipation-Predominant Irritable Bowel Syndrome - The present invention provides methods for treating constipation-predominant irritable bowel syndrome comprising administering to a patient in need thereof, a polymeric proanthocyanidin composition from a 09-24-2009
20100055208Insecticidal Compositions and Uses Thereof - The present invention provides compositions and methods for controlling plant pests. In particular, the present invention provides plant extracts with insecticidal activity.03-04-2010
20120195986PREVENTING OR TREATING PERIODONTAL DISEASES BY HERBAL EXTRACT - A use an extract of Coptidis Rhizoma or a combined extract of Coptidis Rhizoma and Pharbitidis Semen as an active ingredient for preventing and/or treating periodontal disease is provided. The extract of Coptidis Rhizoma or a combined extract of Coptidis Rhizoma and Pharbitidis Semen has activities to stimulate anti-inflammation, osteoblast differentiation and alveolar bone regeneration, and to prevent the alveolar bone destruction, thereby being effective for the prevention and/or treatment of periodontal disease.08-02-2012
20090263510Process of making Hoodia plant extract with improved flavor - Processes of making extracts of 10-22-2009
20100151057MEDICINAL HERBAL EXTRACT HAVING ANTI-OBESITY EFFECT - Disclosed is an anti-obesity active extract obtained from a medicinal plant. More specifically, the extract obtained from lysimachiae foenum-graeci herba (which is a medicinal plant traditionally used in the East) can be used as an active ingredient for a raw material, a functional food, cosmetic, a crude drug, etc. for an obesity preventing or therapeutic agent because the extract can suppress the adipocyte differentiation and decrease the body weight and body fat in an obese animal, thereby suppressing fat accumulation (that is, a factor for obesity).06-17-2010
20090117209ANDROGRAPHIS PANICULATA EXTRACT - An extract of 05-07-2009
20100183750FORTIFICATION OF PLANTS WITH FOLATES BY METABOLIC ENGINEERING - The invention relates to a transgenic plant overexpressing a polynucleotide encoding a plant GTP cyclohydrolase I (GTPCHI) enzyme. The present invention also relates to a product comprising the transgenic plant of the invention or a harvestable part, plant organ, plant tissue, plant cell, seed, or a propagule of said plant. The present invention further elucidate the use of the plant of the invention to cross breed with other plants, as biofortification to enrich the quality of the food intake of an animal or human subject, for the manufacture of a medicament to prevent folate insufficiency, or, for the treatment of folate insufficiency or diseases or disorders resulting from said insufficiency in an animal or human subject.07-22-2010
20100183751COMBINATIONS OF VASOACTIVE SUBSTANCES WITH ESTROGENS AND THEIR USE IN THE TREATMENT OF FEMALE SEXUAL DYSFUNCTIONS - Compositions comprising: 07-22-2010
20110104311Performance Beverage - A performance beverage for underwater diving or other challenging physiological environments.05-05-2011
20110111063Extended Moisturization Cosmetic Compositions - A cosmetic composition providing a skin moisturizing effect over extended periods of time when applied to skin in need thereof is provided. The composition comprises a skin moisturizing sufficient amount of an extract of an air plant in combination with a cosmetically or dermatologically acceptable carrier. Also provided is a method for providing a skin moisturizing effect over extended periods of time. The method comprises applying to the skin in need of a skin moisturizing effect, a composition comprising a skin moisturizing sufficient amount of an extract of air plant in combination with a cosmetically or dermatologically acceptable carrier.05-12-2011
20100227007DIETARY SUPPLEMENTS CONTAINING EXTRACTS OF NELUMBO AND PROCESSES OF USING SAME - Materials derived from 09-09-2010
20110059191BCL-2 PROTEIN EXPRESSING AGENT, APOPTOSIS INHIBITING AGENT AND AGENT FOR PREVENTING ULTRAVIOLET DNA DAMAGE OF EPIDERMAL CELL - An object of the present invention is to provide an apoptosis inhibiting agent which inhibits apoptosis of a cell having a DNA which is directly or indirectly damaged with ultraviolet-rays or the like, enhances the tissue restoring property of a cell, can be added to various drugs, and can be expected to be widely applied.03-10-2011
20100215778Method of Prophylaxis - The method of human prophylaxis comprising a number of steps is claim. First, the client is prepared for a steam bath, by applying a herbal paste on the skin, over at least one area of the client's body. The herbal paste is allowed to be absorbed into the client's body for an amount of time of at least five minutes and is followed with a massage the client's body. The client is then placed into a cedar steam barrel, connected to the steam generator, where the client's body is exposed to the steam. Following the stream procedure, the herbal paste is reapplied, the client's body is massaged, and the client to rests and drinks at least one cup of tea.08-26-2010
20130216632Method for Controlling Hair Growth, Method for Selecting or Evaluating Hair Growth Control Agent, and Hair Growth Suppression Agent - The present invention provides a method for controlling hair growth, a method for selecting or evaluating a hair growth control agent, and a hair growth suppression agent. The present invention provides a method for selecting or evaluating a hair growth control agent, including the steps of administering a test substance to a cell capable of expressing DnaJC6; measuring the expression of DnaJC6 in the cell; and evaluating the controlling effect of the test substance on hair growth based on the expression. The present invention also provides a hair growth suppression agent containing funabarasou (08-22-2013
20100239693CANNABINOID-CONTAINING PLANT EXTRACTS AS NEUROPROTECTIVE AGENTS - The invention relates to the use of cannabinoid-containing plant extracts in the prevention or treatment of neural degeneration. In particular, the invention relates to use of one or more cannabinoid-containing plant extracts in the prevention or treatment of neural degeneration, wherein the one or more cannabinoid-containing plant extracts comprise: i) a cannabinoid-containing fraction; and ii) a non-cannabinoid containing fraction.09-23-2010
20100255124COMPOSITIONS OF VOLATILE ORGANIC COMPOUNDS AND METHODS OF USE THEREOF - The present invention provides compositions and methods for treating, inhibiting or preventing the developing of a plant pathogenic disease. The compositions comprise volatile organic compounds effective to inhibit the growth of, or kill pathogenic microbes, including 10-07-2010
20090169650Food compositions incorporating stearidonic acid - The present invention relates to the improvement of food items through the increased utilization of plant-derived stearidonic acid. Many long chain fatty acids have been classified as being Omega 3 and have been shown to provide several health benefits, including heart health. According to the current invention plant-derived stearidonic acid (18:4ω3) has been incorporated into a wide range of food products by using either oil or flour processed from soybeans with enhanced levels of stearidonic acid. These foods range from oil-based products (salad dressing, mayonnaise) to dairy products (milk, cheese) to prepared foods (entrees, side dishes). In addition to improved health benefits the current invention provides food rich in Omega-3 fatty acids that have enhanced storage and/or shelf life characteristics.07-02-2009
20090324752COSMETIC USE OF ACTIVE INGREDIENTS INCREASING THE PRODUCTION OF GROWTH FACTORS - The invention relates to a cosmetic skin care method, intended to prevent and/or treat at least one cutaneous sign of ageing, including topical application to the skin of a composition containing at least one botanical active ingredient which increases the production by keratinocytes of at least one growth factor chosen from bFGF and PDGF.12-31-2009
20100009016DEHYDROEPIANDROSTERONE PRODUCTION PROMOTER AND USE THEREOF - A new orally administerable DHEA production promoter is provided. A composition containing an extract of at least one selected from the group consisting of plants of 01-14-2010
20090291154 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND/OR PREVENTION OF HYPERLIPIDEMIA, PROCESSES FOR PRODUCING THE SAME AND THE USE THEREOF - The present invention discloses a pharmaceutical composition comprising 11-26-2009
20090142419ANTI-INFLAMMATORY EXTRACT AND AGENT AND METHOD FOR THE PRODUCTION THEREOF - The invention relates to the pharmaceutical industry, in particular to producing herbal remedy for integrally treating various inflammatory diseases. The inventive remedy comprises a dry 06-04-2009
20120141609Melt-Blended Protein Composition - A melt-processed protein composition formed from a protein, plasticizer, and an electrophilic reagent is provided. The electrophilic reagent, for instance, may be selected to undergo a nucleophilic addition reaction with free sulfhydryl and/or thiyl radicals to help minimize the formation of disulfide crosslinking bonds that could otherwise lead to protein aggregation during melt processing. To enhance the degree to which the electrophilic reagent can limit crosslinking, a plasticizer is also employed that helps to mediate the adsorption of the electrophilic reagent into the internal structure of the protein, where it can be more stably retained. Furthermore, the temperature and shear rate employed during melt blending may also be selected to be relatively low to help limit polypeptide dissociation, thereby minimizing the impact of aggregation and embrittlement.06-07-2012
20100112096DRY EXTRACTS OF PELARGONIUM SIDOIDES AND PELARGONIUM RENIFORME - The invention relates to production methods for obtaining dry extracts from 05-06-2010
20100196518Method and Device for the Treatment of Water for Purposes Conducive to Good Health - This invention therefore presents a method and a device for the treatment of drinking water for purposes conducive to good health and the production of wellness and healthcare products. In this method the water to be treated is heavily swirled within a container (08-05-2010
20090142423Use of extracts or extractants of the guajacum types, said extracts or extractants bringing about phosphodiesterase-4 inhibition and method for producing the same - The present invention relates to the use of extracts or extractants of the guajacum types, said extracts or extractants bringing about phosphodiesterase-4 inhibition, and to a method for producing the same.06-04-2009
20100297266Preparations and methods for textile and or fiber surface finishing, surface finished articles prepared thereby, and uses therefor - Disclosed are food compositions, comprising aqueous extracts of 11-25-2010
20100297268AGENT FOR INCREASING BLOOD ADIPONECTIN QUANTITY - An agent for increasing blood adiponectin quantity is provided, the agent including: a pulverized product or extract of a plant of the genus 11-25-2010
20100303933IMMUNOPOTENTIATING COMPOSITION FROM LABISIA PUMILA EXTRACT - The present invention relates to an immunopotentiating composition and to a composition accelerating the production of interferon-[gamma]. More particularly to a process for preparation of water-soluble 12-02-2010
20100316739Chitosan gel for dermatological use, production method therefor and use of same - Pharmaceutical compositions, based on chitosan, which are suitable to leave a protecting coating on the skin, as well as agents conferring curative, soothing and moisturizing properties to sore skins, are protected.12-16-2010
20110111064Anti-Influenza Virus Agent, Anti-RS Virus Agent, and Anti-Immunodeficiency Virus Agent - The present invention herein provides an anti-influenza virus agent, an anti-RS virus agent or an anti-immunodeficiency virus agent, which comprises components originated from plants and which has excellent infectivity-inhibitory effect and proliferation-inhibitory effect against influenza viruses, RS viruses and immunodeficiency viruses. The anti-influenza virus agent, anti-RS virus agent or anti-immunodeficiency virus agent of the present invention comprises an extract derived from, or dry powder of the leaves of a plant belonging to the family Betulaceae and/or a plant belonging to the family Meliaceae.05-12-2011
20110129552Acne Treatment - A kit and method for a two-step acne treatment regimen. The kit comprises a wash composition and a cream treatment composition. The method comprising the steps of: using a wash composition to clean acne affected skin of an individual; and applying a cream treatment composition to the acne affected skin.06-02-2011
20090068293ESTROGENIC EXTRACTS OF Asparagus conchinchinensis (Lour.) Merr of the Liliaceae Family AND USES THEREOF - Estrogenic extracts of 03-12-2009
20090068294ESTROGENIC EXTRACTS OF Rheum palmatum L of the Polygonaceae family AND USES THEREOF - Extracts of various species of the Polygonaceae family have estrogenic properties. For example, aqueous and ethanolic extracts of 03-12-2009
20090068291Plant extracts and compositions comprising extracellular protease inhibitors - The present invention provides a plant derived extract comprising inhibitory activity against one or more extracellular proteases which degrade human tissue matrix. Moreover, the amount of inhibitory activity in an extract can be increased by stressing the plant prior to forming an extract. These extracts are each prepared by a standard process and demonstrate the ability to inhibit one or more extracellular proteases which degrade human tissue matrix. Libraries of extracts can be prepared from stressed and non-stressed plants, wherein each of the extracts demonstrate inhibitory activity against one or more extracellular protease inhibitors. Alternatively, semi-purified and purified inhibitory compounds can be isolated from the extracts following standard procedures. In one aspect, these extracts with inhibitory activity can be used during protein purification to minimize the degradation due to extracellular proteases.03-12-2009
20110014305Extracts of eleutherococcus spp., preparation method thereof and use of the same - The present invention relates to extracts of 01-20-2011
20090035395SPONDIAS MOMBIN L. EXTRACT AND METHODS OF EXTRACTING AND USING SUCH EXTRACT - A method of inhibiting COX-2, inhibiting NF-Kappa B activation, treating inflammation, or treating cancer may comprise administering a therapeutically effective amount of an extract of 02-05-2009
20090035396Novel reference plant, a method for its production, extracts obtained therefrom and their use - The invention relates to a reference plant which has been selected to: 02-05-2009
20110033561USE OF PHYTOECDYSONES IN THE PREPARATION OF A COMPOSITION FOR ACTING ON THE METABOLIC SYNDROME - For reducing the negative effects of the metabolic syndrome on mammal organisms, it is proposed to use phytoecdysones for diminishing the fat body mass in individuals, notably with a weight excess. Phytoecdysones are advantageously incorporated into a food composition. The phytoecdysones can come from food plants, such as quinoa.02-10-2011
20080274214Medicament For The Prevention and Treatment Of Influenza - The invention relates to the use of an extract from plants of the genus 11-06-2008
20110244060CARDIOPROTECTIVE EFFECTS OF NUTRACEUTICALS ISOLATED FROM NIGELLA SATIVA SEEDS - This invention relates to a rich antioxidant nutraceuticals prepared from 10-06-2011
20110142966AQUEOUS EXTRACTS OF ANOECTOCHILUS SPP. KINSENOSIDE AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR HEPATOPROTECTION - A pharmaceutical composition useful for hepatoprotection is provided. The composition comprises an effective amount of kinsenoside or a pharmaceutically acceptable salt or ester thereof. An aqueous extract of 06-16-2011
20100255125PROCESS FOR COSMETIC TREATMENT USING FERUTININE FROM FERULA GENUS PLANTS - The invention relates to a process for cosmetic treatment, including the reduction of superficial and deep wrinkles, using ferutinine from 10-07-2010
20100215779Compositions and Methods for Treating Disorders Associated with Salt or Fluid Retention - Methods for reducing the risk of or treating a disorder associated with fluid and/or salt retention in a patient are described. The methods include administering to the patient an agent selected from: a) an agent that reduces sodium absorption in the intestine; b) an agent that increases anion secretion in the intestine; or c) an agent that both reduces sodium absorption in the intestine and increases anion secretion in the intestine.08-26-2010
20100003351COMPOSITIONS COMPRISING RHODIOLA ROSEA AND METHODS OF USE THEREOF - The present invention relates to compositions and kits comprising an extract of 01-07-2010
20100062086Compositions and Methods of Their Use for Improving the Condition and Appearance of Skin - The present invention relates to compositions and methods for treating, preventing and improving the condition and aesthetic appearance of skin, particularly, treating, preventing, ameliorating, reducing and/or eliminating fine lines and/or wrinkles of skin, where the compositions include natural plant constituents, or synthetic equivalents thereof, which inhibit or decrease expression of C-reactive protein expression, production or secretion, thereby reducing, inhibiting, or ameliorating dermatological signs of aging. The compositions of the invention may be topically applied to the skin, or are delivered by directed means to a site in need thereof, in an amount effective in improving the condition and aesthetic appearance of skin.03-11-2010
20110177175DIETARY FIBER COMPOSITIONS - The present invention relates to dietary fiber compositions comprising fenugreek dietary fibers. The present invention also relates to use of these compositions as dietary supplements, functional foods or pharmaceutical preparations for promoting satiety and weight loss, lowering cholesterol, controlling blood glucose, maintaining colon health and modulating inflammation.07-21-2011
20100062085TREATMENT OF DAMAGED SKIN - A medicament for treating skin is described. It comprises essentially of 03-11-2010
20100055209 Standardized Extract And Its Use In The Manufacture Of A Medicament - The present invention refers to a medicament which activates gastrointestinal movement. The medicament consists essentially of Cucurbitacin D and one or more substances form the group including Cucurbitacin A, Cucurbitacin B, Cucurbitacin E, Isocucurbitacin B and Isocucurbitacin D. The medicament is made from an extract obtained from Muskmelon Base, the fruit stem of 03-04-2010
20090028967FLUID KONJAK MATERIAL AND ITS PRODUCTION AND USE - A fluid konjak material, which can be mixed with any other edible material uniformly at a high concentration while sufficiently keeping the gelling power and the biological effect intrinsic to konjak mannan, is provided by swelling and dissolving konjak flour in water, treating the resultant with alkali at a pH of at least 10, lowering the pH to less than 8, heating the composition with forced stirring and enzymatically treating the forcedly-stirred composition.01-29-2009
20090214678Herbal Formulation for the Prevention and Management of Diabetes Mellitus and Diabetic Micro-Vascular Complications - A novel herbal formulation for the prevention and management of diabetes mellitus and its significance in the prevention of diabetic micro-vascular complications. A novel herbal formulation for the prevention of endothelial dysfunction Diabetes Mellitus and Diabetic Micro-Vascular complications comprising: 08-27-2009
20090214676METHOD FOR TREATING OCULAR DEMODEX - The present invention relates to a method for treating a disorder chosen from ocular 08-27-2009
20110104310Method of Manufacturing Magnoliidae Compounds - Magnoliidae compounds are made by obtaining parts of Magnoliidae plants. The parts of the Magnoliidae plants are mixed with alcohol and water. The mixture of the parts of the Magnoliidae plants, alcohol and water is heated and the parts of the Magnoliidae plants are removed so that a liquid mixture remains. The liquid mixture is drying to form a solid composition. Alcohol and water are added to the solid composition to reconstitute the solid composition into a liquid composition. The liquid composition is heated to form solid matter. The solid matter is dried to obtain a purified composition of the Magnoliidae compounds. A dose of Magnoliidae compounds promotes weight loss and can be administered in liquid form, sublingually, intravenously, in a pharmaceutically acceptable carrier, in combination with a metabolite detoxification agent, in combination with a nutritional or dietary supplement, or in chewing gum.05-05-2011
20110059190CISTUS EXTRACT CONTAINING ENRICHED SECONDARY PLANT INGREDIENTS - The invention relates to a method for producing an extract containing at least 40% (m/m) of polyphenols from 03-10-2011
20110151029Paxillin Stimulating Compositions and Cosmetic Uses Thereof - Cosmetic compositions comprising one or more paxillin stimulators and methods of using such compositions to impart anti-aging benefits to the skin are disclosed. The paxillin stimulators and combinations thereof are believed to have modulatory activity against at least one biochemical pathway implicated in skin aging.06-23-2011
20120171309FORMULATIONS AND METHODS FOR INCREASING EFFICACIES AND IMPROVING FLAVORS OF FORMULATIONS CONTAINING GYNOSTEMMA PLANT - Formulations and methods for increasing efficacies and flavors of jiaogulan (07-05-2012
20080248139PROCESS FOR THE PREPARATION OF FERUTININE FROM FERULA GENUS PLANTS - The invention relates to a process for the preparation of ferutinine (Ia) from 10-09-2008
20080248138TOPICAL OIL FOR TREATING PHYSICAL AILMENTS AND METHOD FOR MAKING AND APPLYING THE SAME - A method for making and applying a topical oil and composition thereof, combining the healing properties of the Noni plant with a topical application for treating physical ailments. The topical oil disclosed includes an oil derived from raw leaves, stems, and buds of a noni plant; a carrier oil; and vitamin E oil.10-09-2008
20110151030COMPOSITIONS FOR ALLEVIATING INFLAMMATION AND OXIDATIVE STRESS IN A MAMMAL - An antioxidant-promoting composition that increases antioxidant defense potential in a subject is disclosed comprising 06-23-2011
20110151028Topical vaginal preparation - A topical pharmacological preparation in the form of cream, suppositories or drops delivered topically to the vagina in order to contract the smooth muscle of the vaginal wall. The preparation contains a smooth muscle contracting agent such as oxytocin capable of constrict the vaginal tube reducing its overall diameter for a more pleasurable sexual experience for the female subject and his partner alike. The smooth muscle contracting agent can be associated with a systemic absorption retardant such as a mixture of Benzyl Alcohol, Acetone and Isopropanol. Such a formulation achieves high local tissue concentration of the smooth muscle contraction substance such as oxytocin in vicinity to the site of application, via minimization of systemic absorption of the smooth muscle contraction inducing substance and at the same time via promotion of its submucosal absorption across the mucosal barrier. As a result of the use of such formulation an increased local smooth muscle contraction activity is expected to occur in the muscularis mucosae.06-23-2011
20090258093Use of a brassocattleya marcella koss orchid extract as an active agent to prevent or delay the appearance of signs of cutaneous aging - The present invention describes the use of an extract from the 10-15-2009
20110256246ESSENTIAL OIL OF KUNZEA AMBIGUA AND METHODS OF USE - A method for treating such ailments as, or otherwise reducing the effects of, irritable bowel syndrome, hemorrhoids, symptoms of the common cold, improving the condition of lesions and ulcers of the type often attendant certain cancers, such as cancer of the jaw and mouth scrub typhus (tick fever), certain sinus infections, whooping cough, tooth abscesses and inflammation, including the inflammatory effects associated with auto-immune diseases, particularly, Crohn's disease, which method includes the steps of obtaining an essential oil of Kunzea ambigua and internally administering the essential oil of Kunzea ambigua via inhalation, ingestion or via application to an infected area, if feasible.10-20-2011
20110177174Fruit chocolate - An intimately incorporated meltaway confection highlighting a fruit/fruit blend whose primary fat constituent is cocoa butter, having anhydrous, powdered freeze-dried fruit/fruit juices, and other fruit essences and oils, along with dairy and nutritive carbohydrate sweeteners. Additional flavorings, emulsifiers and fruit based acids may be added to further enhance palatability. Fruit/botanical blends would be achieved by adding an anhydrous powdered botanical component prior to conching. The conching process would employ a constant conching pressure for all aforementioned components of the present invention in order to create a smooth texture and mouth-feel. Further optional components comprise inclusions and coatings typical of other chocolate confections, in addition to metabolic compounds and medicinals for further health benefits.07-21-2011
20080226754METHOD FOR TREATMENT OF CARTILAGE DISORDERS WITH CENTELLA EXTRACT - The invention is a method for the treatment of mammalian articular cartilage disorders, inflammatory joint disease, trauma-related cartilage injuries, and degenerative disc disease. The method involves treating the affected area with a composition containing a therapeutically effective dose of 09-18-2008
20080220099Nutritional composition - A dietary supplement for dogs is disclosed. The composition is a blend of methyl sulfonyl methane, glucosamine sulfate, chondroitin sulfate, ascorbic acid, phylloquinone, yucca powder and stabilized rice bran. The composition may be added to a variety of meat products for dogs, preferably beef and/or beef by-products.09-11-2008
20080220096CYNARA SCOLYMUS EXTRACTS AND COMPOSITIONS CONTAINING THEM - The present invention relates to a 09-11-2008
20080254148HERBAL COMPOSITIONS FOR THE INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS - The invention provides a herbal composition for the inhibition of HIV, comprising an organic extract of 10-16-2008
20110165272ANTIALLERGIC COMPOSITION - An antiallergic composition that is moderate for the human body and skin, and has reduced side-effects that comprises a cold-water extract from hop tissue or flavonoid glucosides separated from the cold-water extract from hop tissue.07-07-2011
20110165271ANTITUMORAL TERPENOID PHARMACEUTICAL COMPOSITION 'ABISILIN' EXHIBITING ANGIOGENESIS-INHIBITING ACTION - The invention relates to medicine and the chemical and pharmaceutical industry and to agent for treating diseases caused by angiogenesis regulation disorders, in particular to a method for treating oncological diseases of different genesis by inducing angiogenesis inhibition which is secondary to the direct antitumoral, anti-reccurant and anti-metastatic action as well as by the associated activation of the apoptosis endogenous system. The invention uses a novel peroral medicinal form ‘Abisilin’, comprising ingredients relating to the class of natural terpene compounds (isoprenoids), produced from coniferous threes of a Pinaceue family, which medicinal form contains: sesquiterpenoids (3-6%), neutral diterpenoids (11-15%), diterpene acids (22-28%), triterpene acids (8-16%), unsaturated and saturated fatty acids (0.1-0.3%), phenolic compounds (0.1-0.2%), monoterpenoids being the rest, wherein the bornyl acetate content is equal to not less that 10.0% of the total terpene composition. It is expected that the use of the novel peroral medicinal form ‘Abisilin’, the substance of which exhibits immunomodulating, antibacterial, antiinfiammatory, anesthetic, wound-healing and other pharmacologically-significant actions, is free of contra-indications and toxic effects and can be used together with different agents, provides a novel therapeutic approach and enhances the efficiency of treatment of oncological and many other diseases caused by angiogenesis process disorders.07-07-2011
20110165270Environmentally-friendly substratum composition for a variety of personal products - A substratum composition derived entirely from naturally occurring ingredients chosen for their detoxifying, cleansing, and rejuvenating properties, and blended in effective proportions. Additionally, composition constituents are scrutinized and screened for environmental neutrality, thereby eliminating traditional impacts on community watersheds. The all-natural composition may serve as a substratum for a variety of personal hygiene, haircare, skincare, and cosmetic products.07-07-2011
20100285153Lipolysis Stimulator - To provide a lipolysis agent, a slimming agent, and a cellulite-ameliorating agent, which stimulate decomposition of fat accumulated in the adipose tissue, to thereby exhibit body-slimming effect and which is effective for inhibition or prevention of obesity and amelioration of prone to obesity. The lipolysis stimulator of the invention contains, as effective ingredients, a plant Huang Hua Cai or an extract thereof, and a xanthine derivative.11-11-2010
20100285154USE OF LIGNAN COMPOUNDS FOR TREATING OR PREVENTING INFLAMMATORY DISEASE - The present invention relates to the use of lignan compounds for treating or preventing an inflammatory disease. More particularly, it relates to a method for preventing or treating an inflammatory disease, comprising administering to a subject in need thereof an effective amount of macelignan represented by Chemical Formula I or a pharmaceutically acceptable salt thereof. The lignan compound has the effect of inhibiting inflammatory reactions by inhibiting the production or expression of inflammation mediators NO, iNOS, PGE11-11-2010
20100285156COMPOSITION FOR PREVENTING AND TREATING METABOLIC DISEASES COMPRISING THE EXTRACT OF LYSIMACHIAE FOENUM-GRAECI HERBA - Disclosed are raw material, functional foods, and herb medicines for preventing and treating metabolic diseases, which comprise a Lysimachiae Foenum-Graeci Herba extract as an effective ingredient. The Lysimachiae Foenum-Graeci Herba extract have an activity of reducing blood glucose levels, triglycerides and cholesterol levels, AST and ALT levels, and fat in the liver, and thus can be effectively used as a hepatic protector and a remedy for preventing and treating various metabolic diseases including diabetes, high blood pressure, fatty liver, cardiovascular diseases, and hyperlipidemia.11-11-2010
20110256245METHODS AND COMPOSITIONS OF CANNABIS EXTRACTS - In one embodiment, a method is provided for obtaining an extract from a cannabis plant for medical uses. In one embodiment, a method for obtaining an extract from a cannabis plant for medical uses is provided. The method comprises (a) providing cannabis flower trimmings with trichome material, (b) providing clean, cold water to at least cover cannabis the cannabis flower trimmings, (c) agitating the mixture of cannabis flower trimmings and water (d) soaking the cannabis flower trimming in cold water for at least one minute, (e) removing cannabis flower trimmings from the water, (f) removing the trichome material from the water and (g) drying the trichome material to contain no more than 10% total water weight.10-20-2011
20100323038Pharmaceutical Compositions - The present invention relates to an improved mode of administration for cannabis and its natural and synthetic derivatives. A pharmaceutical composition suitable for sublingual aerosol or spray delivery of cannabis is provided. The formulation may be dispensed using a pump spray or the formulation may include a propellant, such as butane, 1,1,1,2-tetrafluoroethane (HFC-134a) or 1,1,1,2,3,3,3-heptafluoropropane (HFC-227). The term cannabis is used herein to refer to all physiologically active substances derived from the cannabis family of plants and synthetic cannabis analogues and derivatives, precursors, metabolites etc., or related substances having cannabis-like physiological effects.12-23-2010
20100323039LABISIA PUMILA EXTRACTS FOR REDUCING THE RISK OF CARDIOVASCULAR DISEASES - There is disclosed a standardised aqueous extract of 12-23-2010
20110091581New pharmaceutical function of dichroa febrifuga alkone derivative (DFAD) - A safe pharmaceutical composition for antioxidation, controlling oncoges, inhibiting tyrodine kinase activity and increasing immune function contains 04-21-2011
20100166890ANTITUSSIVE COMPOSITION AND METHOD FOR MAKING THE SAME - An antitussive composition is provided. A pharmaceutical composition for relieving, preventing and/or treating a cough includes a sufficient amount of the 07-01-2010
20100068312FORMULATION FOR FEVER REDUCING TREATMENT AND A METHOD AND KIT FOR USING THEREOF - A fever reducing formulation comprising an aqueous solution of acetic acid, sweating inducing plant extracts and fragrant masking ingredients. The solution of acetic acid and the plant extract reduce fever while the fragrant masking ingredients mask the smell of the acetic acid. A kit for reducing fever comprising the above mentioned fever reducing formulation, as well as a container for mixing the formulation, an absorbing material for applying the formulation to the skin and an information and instruction sheet. A method for reducing fever comprising mixing the formulation, moistening an absorbing material with the formulation and applying the absorbing material to the skin.03-18-2010
20100055211PROCESS FOR PRODUCING REFINED NUTRACEUTIC EXTRACTS FROM ARTICHOKE WASTE AND FROM OTHER PLANTS OF THE CYNARA GENUS - Process for fractioning and refining natural products obtainable from waste vegetal material and particularly from artichoke (03-04-2010
20090202663PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OTOMYCOSIS - Disclosed is a composition comprising betamethasone, griseofulvin and tea tree oil, for use in the treatment of ear fungal infections, particularly otomycosis, particularly infections caused by Aspergillus niger or Candida albicans. The composition may be in the form of ointment, cream, gel or liquid, e.g. ear drops.08-13-2009
20090196940COMPOSITIONS AND METHODS FOR SUPPORTING HEAT SHOCK FUNCTION - Compositions and methods for promoting or maintaining protein accretion in cells, particularly in skeletal muscle cells, by supporting heat shock protein function. The compositions comprise glutamine and additional components directed at enhancing the activity of heat shock proteins.08-06-2009
20090175964Composition for enhancing immunity - Disclosed is an edible composition for enhanced immunity comprising theanine or a source of theanine and a herb selected from Shankhpushpi, Shatavari, or a mixture thereof.07-09-2009
20110189312Compositions and Methods for Supporting Heat Shock Protein Function - Compositions and methods for promoting or maintaining protein accretion in cells, particularly in skeletal muscle cells, by supporting heat shock protein function. The compositions comprise glutamine and additional components directed at enhancing the activity of heat shock proteins.08-04-2011
20110189311Highly Absorbable Drug Composition and Method of Producing the Same - Provided is a highly absorbable drug composition including one or more water-soluble compound (A) selected from an enzyme-treated hesperidin, a stevia extract, or an enzyme-treated stevia and a poorly water-soluble drug (B) selected from flurbiprofen or probucol.08-04-2011
20110189313Method of using a green coffee bean extract to promote carnitine palmitoyltransferase activity - (Problems) To provide a highly safe dietetic composition originating in green coffee beans by which excellent dietetic effects can be obtained and which contributes to the prevention and treatment of life style-related diseases such as diabetes.08-04-2011
20100028465COMPOSITION FOR AMELIORATING CEREBRAL FUNCTION - Provided is a substance which is a safe material such as a food component and an extract of a natural product and has a stronger effect of ameliorating a cerebral function (effect of ameliorating a metabolism of monoamines as an intracerebral neurotransmitter and ameliorating deterioration in memory and learning due to hypofunction of a cholinergic neuron). The present invention provides a composition for ameliorating a cerebral function, comprising an alkali-stable lipid from an acetic acid bacterium, N-acylsphinganine or N-2′-hydroxypalmitoyl-sphinganine, as an active ingredient.02-04-2010
20100028463EXTRACT OF STEWARTIA KOREANA AND USE THEREOF - The present invention relates to an extract of 02-04-2010
20100028466CAROTENOID COMPOSITIONS CONTAINING MODIFIED GUM ACACIA - The present invention relates to compositions containing modified gum acacia and carotenoids, wherein the gum acacia has been subjected to a heat-treatment at a temperature between 100° C. and 115° C. for 1 to 38 hours, wherein the composition comprises less than 40 weight-% oil. It has been found that the compositions according to the invention allow to produce emulsions having a very high color intensity, color stability. These compositions can be used for the enrichment, fortification and/or coloration of food beverages, animal feed, cosmetics or pharmaceutical compositions. The present invention also refers to the preparation of such compositions, wherein it has been found that the emulsification time in the manufacturing process of the compositions can be reduced when using a modified gum acacia in carotenoid compositions with less than 40 weight-% oil. The present ‘invention furthermore refers to a process for the manufacture of a beverage by mixing the compositions with ingredients of beverages. The present invention also refers to beverages obtainable by this process.02-04-2010
20100021568Anti-Obesity Product And Its Method Of Preparation - The present invention relates to compositions comprising one or more anthraquinones for use in the treatment of obesity and related metabolic and liver disease. More particularly it relates to a plant extract fraction rich in anthraquinones including both anthraquinone glycosides and anthraquinone aglycones obtainable from a member of the Leguminosae family, more particularly 01-28-2010
20120034322INTESTINAL BACTERIAL FLORA DISTRIBUTION RATIO REGULATOR - A food or pharmaceutical capable of regulating an intestinal bacterial flora distribution ratio, which is safe and has few side effects, is provided.02-09-2012
20100303934METHODS AND COMPOSITIONS FOR NERVE REGENERATION - A method of promoting nerve regeneration in a subject that includes administering to the subject a therapeutically effective amount of a composition that includes at least one therapeutically-active extract fraction of 12-02-2010
20100040706METHOD OF ANTI-AGEING COSMETIC CARE BY STIMULATION OF SURVIVIN EXPRESSION - The invention relates to a cosmetic care method comprising the delivery of an effective amount of at least one cosmetically acceptable agent that activates or stimulates survivin expression in the stem cells of the basal layer of the epidermis. The invention makes it possible in particular to prevent or delay the appearance of the signs of skin aging or to treat them.02-18-2010
20100129475ESSENTIAL OIL OF KUNZEA AMBIGUA AND METHODS OF USE - A method for treating disease includes the steps of obtaining the essential oil from the Kunzea ambigua plant and administering the essential oil obtained to a human to take internally. The essential oil of the Kunzea ambigua plant has been discovered to act positively against parasitic infestation of humans and animals, and also has been found to have high kill rates against various viral and bacterial infections.05-27-2010
20090098223NATURAL PLANT EXTRACT COMPOSITION FOR PREVENTION AND RECOVERY OF HYPERLIPIDEMIA AND STROKE, NATURAL TEA CONTAINING THE SAME AS ACTIVE INGREDIENT AND METHOD FOR PREPARING THE NATURAL TEA - A natural plant extract composition for the recovery and prevention of hyperlipidemia and stroke, a natural tea comprising the same as an active ingredient, and a method for preparing the natural tea. The natural plant extract composition contains a 04-16-2009
20080317879Herb Composition for Asthma Maintenance Therapy and Manufacturing Method Thereof - The present invention relates to a herb composition for asthma maintenance therapy based on Chungsangboha-tang, which is known to be effective in asthma, capable of reducing the long-term suffering of asthma patients and improving their quality of lives and a manufacturing method thereof. The herbal composition of the present invention is characterized by comprising 5-18 parts by weight of 12-25-2008
20080286385Method of Obtaining Avocado Powder - The invention relates to avocado powder and to the method of obtaining the same. Avocado powder is a novel product which enables the avocado to be preserved for an extended period of time at ambient temperature, such as to conserve the characteristic properties of the product, with the additional advantage of being 100% natural and occupying less physical storage space, thereby eliminating the post-processing cold chain. The method of obtaining avocado powder comprises a series of operations or steps that terminate in the pulverization and packing of the end product.11-20-2008
20100221364COMPOSITIONS AND METHODS OF INDUCING HAIR GROWTH UTILIZING COTINUS COGGYGRIA - This application relates to compositions and methods for inducing hair growth and improving hair quality utilizing extracts of 09-02-2010
20090232913Composition for the Control of Cholesterol Levels - The present invention relates to a composition used to control cholesterol levels. In particular, the present invention relates to a method for the treatment or prevention of disorders or diseases mediated by hyperlipidemia, said method comprising administering to a mammalian subject in need thereof an effective amount of a composition comprising an extract from at least one plant from the genus 09-17-2009
20110117216ANTI-TUMOURAL EFFECTS OF CANNABINOID COMBINATIONS - The invention relates to the use of a combination of cannabinoids, particularly tetrahydrocannabinol (THC) and cannabidiol (CBD), in the manufacture of a medicament for use in the treatment of cancer. In particular the cancer to be treated is a brain tumour, more particularly a glioma, more particularly still a glioblastoma multiforme (GBM).05-19-2011
20100233298COSMETIC USE OF PHYTOSPHINGOSINE AS SLIMMING AGENT AND COSMETIC COMPOSITIONS COMPRISING PHYTOSPHINGOSINE - The invention relates to novel cosmetic uses of phytosphingosine or of one of its cosmetically acceptable salts, particularly its hydrochloride, as a slimming agent and/or as an active agent which stimulates the synthesis of leptin by adipocytes, for preparing a cosmetic composition intended for reducing subcutaneous excess fat.09-16-2010
20090061028PESTICIDAL/OVICIDAL COMPOSITION AND PESTICIDAL/OVICIDAL METHOD - A pesticidal/ovicidal composition comprising: (a) 50-97.9 parts by mass of a triglyceride containing not less than 50% of oleic acid as a fatty acid component; (b) 0.1-20 parts by mass of a cationic surface active agent; and (c) 2-30 parts by mass of a glycerin derivative, and a pesticidal/ovicidal method using the same. The composition according to the invention has not only a pesticidal activity but also an ovicidal activity on crop pests, and provides a safe and high pesticidal/ovicidal effect.03-05-2009
20090017141TOPICAL COMPOSITION FOR THE TREATMENT OF HYPERPIGMENTED SKIN - The present invention relates to novel, topically applied, cosmetic/dermatological compositions for the treatment of hyperpigmentation disorders and photodamaged human skin. The subject compositions combat hyperpigmented skin. In addition, the compounds described can be used in the treatment of many other pathologies. Due to a high degree of gentleness, along with potent antioxidant and moisturizing effects, the present invention can be used safely in the treatment of many conditions, such as the prevention and/or treatment of melasma, freckles, age spots (lentigo senilis) and photodamaged skin.01-15-2009
20080233214Therapeutic Compounds Isolated from Calomeria Amaranthoides - The present invention relates to extracts and compounds which are isolated from Calomeria amaranthoides, and to derivatives and analogues of such compounds, which demonstrate cytotoxic activity against a variety of cell types exhibiting hyperproliferative cell division.09-25-2008
20120040026AROMATASE INHIBITOR - A substance is disclosed that can inhibit the activity of aromatase (an enzyme capable of converting androgen into estrogen) to thereby effectively treat and/or prevent a sex hormone-dependent disease such as breast cancer occurring in a female person after menopause, as well as a climacteric disorder in a male person and metabolic syndrome caused by the accumulation of a visceral fat. Specifically, a therapeutic and/or prophylactic agent for a sex hormone-dependent disease comprises at least one herbal extract selected from the group consisting of “Kokeiten,” prunella spike, sweet hydrangea leaf, milk thistle, a jasmine tea, “Bokusoku,” “Tencha,” “Karensou,” “Youbaihi,” French maritime pine, betel palm, asparagus, “Rouro,” “Ryoukyou,” rooibos tea, rhubarb, pu-erh tea, green tea, “Ougon,” St. John's wort, licorice, “Senrikou,” wintergreen, “Kashi,” “Yagotou,” polygnum root, barrenwort, guarana, “Ouhi,” Argy's wormwood, sticky rehmannia, Japanese cornel, Asiasarum root, cinnamon, peony root, pine needle and amla fruit.02-16-2012
20120040027FOOD OR BEVERAGE COMPOSITION COMPRISING UNROASTED COFFEE SOLIDS - The present invention relates to a food or beverage composition comprising unroasted coffee solids and arabinogalactans, for example a ready-to-drink beverage.02-16-2012
20120040025Compositions and Methods for Treating Disorders Associated with Salt or Fluid Retention - Methods for reducing the risk of or treating a disorder associated with fluid and/or salt retention in a patient are described. The methods include administering to the patient an agent selected from: a) an agent that reduces sodium absorption in the intestine; b) an agent that increases anion secretion in the intestine; or c) an agent that both reduces sodium absorption in the intestine and increases anion secretion in the intestine.02-16-2012
20080199543Pharmaceutically Active Extracts of Vitex Leucoxylon, a Process of Extracting the Same and a Method of Treating Diabetes and Inflammatory Diseases Therewith - The present invention relates to pharmaceutically active extracts of 08-21-2008
20080220098FORMULATIONS OF ALPHA-AMYLASE INHIBITORS WITH ALPHA-GLUCOSIDASE INNHIBITORS USEFUL IN THE TREATMENT OF DIABETES AND OBESITY - This invention relates to the combination of α-amylase inhibitors prepared from 09-11-2008
20100255123SKIN MOISTURIZER, BLOOD CIRCULATION PROMOTER, AND EXTERNAL PREPARATIONS FOR THE SKIN CONTAINING THE SKIN MOISTURIZER AND THE BLOOD CIRCULATION PROMOTER - An object of the present invention is to provide a moisturizer having excellent moisturizing effects, and a blood circulation enhancer having blood circulation-promoting effects. A plant belonging to the genus 10-07-2010
20090214677Pharmaceutical Composition Containing an Extract of a Solidago Species - An extract of a part of a 08-27-2009
20100209543COMPOSITIONS AND METHODS OF USE - This invention relates to the use of plant extracts, compositions thereof, and compounds isolated from plant extracts or obtained from synthetic means thereof, for the treatment of diseases, disorders or symptoms thereof (e.g., proliferation disorders, cancer).08-19-2010
20080279966Branched-chain amino acid composition for improving skeletal muscle protein metabolism - The present invention relates to compositions and methods for improving skeletal muscle protein metabolism through encouraging skeletal muscle protein synthesis, reducing skeletal muscle protein degradation, and attenuating inflammatory signaling in exercising muscle.11-13-2008
20080268073CERAMIDASE INHIBITOR - The present invention provides a ceramidase activity inhibitor which inhibits ceramidase activity, specifically neutral/alkaline ceramidase activity, characterized in that the inhibitor comprises, as an active ingredient, a processed product derived from at least one plant selected from the group consisting of plants belonging to Ginkgoaceae, plants belonging to Cucurbitaceae, plants belonging to Rutaceae, plants belonging to Laminariaceae, plants belonging to Myrtaceae and plants belonging to Compositae, and a medicament, a quasi-drug, cosmetics and a food, each comprising the inhibitor.10-30-2008
20110318433SOOTHING PHARMACEUTICAL OR COSMETIC COMPOSITION COMPRISING A PEPTIDE THAT ACTIVATES HMG-COA REDUCTASE - The present invention relates to a soothing cosmetic or pharmaceutical composition comprising at least one peptide that activates human HMG-CoA reductase of general formula (I):12-29-2011
20100143508Limonene and yucca medical compound for treating human diseases and conditions - A medical compound for treating a wide variety of human diseases and conditions comprises a medically effective amount of a yucca extract, an effective delivery-enhancing amount of d-Limonene and an organic solvent as the active components. The inactive components include one or more inert solvents and an inert emulsifier. In the preferred embodiment, the yucca extract is Sarsasapogenin at 45% by volume, the d-Limonene is in an amount of 19.1% by volume and the organic solvent is 2-Butoxyethanol at 13.5% by volume. The inert components, making up the rest of the compound, are the inert solvent isoparaffinic fluid, the inert emulsifier sodium dodecylbenzene sulfonate and the inert solvent isopropylamine. The medical compound has a unique delivery system that readily enters the systemic circulation and rapidly reaches the target tissue and/or organs to quickly begin the process of restoring and healing the patient by boosting his or her immune system.06-10-2010
20120171308Antioxidant Complex, Cosmetic and Pharmaceutical Compositions Containing Said Complex, and Use of Said Complex - The present application describes an antioxidant complex having a synergistic effect between its ingredients. Said mixture comprises: a) vitamin E and/or derivatives thereof; b) green tea extract and/or derivatives thereof; and c) cacao extract. Examples of cosmetic and pharmaceutical compositions comprising said antioxidant complex and a physiologically acceptable carrier are also described. The antioxidant complex of the present invention, as well as the aforementioned compositions, aid in preventing and protecting against cell and skin damages resulting from the action of free radicals, and also provide DNA, protein and cell membrane protection.07-05-2012
20120003332Compositions and Methods for Stimulation MAGP-1 to Improve the Appearance of Skin - The present disclosure relates to methods for treating, preventing and improving the condition and aesthetic appearance of skin, particularly, treating, preventing, ameliorating, reducing and/or eliminating fine lines and/or wrinkles of skin, by application of one or a combination of natural compounds or extracts that stimulate MAGP-1 expression and which improves the appearance of aged and/or photodamaged skin. The compositions of the invention are topically applied to the skin, or are delivered by directed means to a site in need thereof in an amount effective to improve the condition and aesthetic appearance of skin.01-05-2012
20120003333Method of Removing Ticks from the Skin and Reducing the Risk of Bites - Compositions and method of using the same for the removal of ticks embedded in the skin or tissue of a human or animal host and for preventing ticks from attaching themselves to and biting humans or other animals.01-05-2012
20120003331Use of Tiliacora Triandra in Cosmetics and Compositions Thereof - The present disclosure relates to compositions and methods for treating, preventing and improving the condition and aesthetic appearance of skin, particularly, treating, preventing, ameliorating, reducing and/or eliminating fine lines and/or wrinkles of skin, where the compositions include natural plant constituents which increase expression levels genes, collagen replacement and retention, and cell proliferation of epidermis and dermis associated with the dermatological signs of aging. The compositions of the invention are topically applied to the skin, or are delivered by directed means to a site in need thereof, once daily in an amount effective in improving the condition and aesthetic appearance of skin.01-05-2012
20090280197CELL ACTIVATOR, COLLAGEN PRODUCTION PROMOTER, SKIN WHITENING AGENT, ANTIOXIDANT AGENT, ANTIINFLAMMATORY AGENT, AROMATASE ACTIVITY PROMOTER, PROTEASE ACTIVITY PROMOTER, EXTERNAL PREPARATION FOR SKIN, AND FOOD - The present invention provides a cell activation agent, a collagen production accelerator, a whitening agent, an antioxidant, an anti-inflammatory agent, an aromatase activity accelerator, a protease activity accelerator, a skin external preparation, and food, which all contain an extract of 11-12-2009
20100233300BIO-DERIVED 1,3-PROPANEDIOL AND ITS CONJUGATE ESTERS AS NATURAL AND NON IRRITATING SOLVENTS FOR BIOMASS-DERIVED EXTRACTS, FRAGRANCE CONCENTRATES, AND OILS - Compositions comprising 1,3-propanediol and an extraction product are provided, and the 1,3-propanediol in the composition is biologically derived. Also provided are processes for extracting an extract from a source. These processes comprise providing an ester of 1,3-propanediol and mixing the 1,3-propanediol ester with the source. This serves to extract the extract from the source into the ester. The processes also include separating the source from the ester and extract. Also provided are compositions comprising an ester of 1,3-propanediol and an extraction product. In these compositions, the ester can have at least 3% biobased carbon.09-16-2010
20090285910Composition Comprising the Extract of Dioscorea Opposita Thunb Showing Neuronal Cell-Protecting Activity for Preventing and Treating Brain Disease - The present invention relates to a composition comprising an extract of 11-19-2009
20120009281PLANT EXTRACTS FOR TREATING SKIN DISORDERS AND ENHANCING HEALING OF WOUNDS FOR DIABETIC PATIENTS - The present invention provides a pharmaceutical composition for treating skin disorders, including enhancing the healing of wounds for diabetic patients. Specifically, this invention relates to the use of the extracts of 01-12-2012
20090274777Dietetic composition - (Problems) To provide a highly safe dietetic composition originating in green coffee beans by which excellent dietetic effects can be obtained and which contributes to the prevention and treatment of life style-related diseases such as diabetes.11-05-2009
20090232912Method For Preparing Extract For The Prevention and Treatment Of Hyperlipidemia and Obesity From the Extract of Aster Spathulifolius Aerial Part and Composition Containing The Same - The present invention relates to a method for preparing an extract of the aerial part of 09-17-2009
20100021569Use of Extracts from AMTHS plants in Lowering Blood Glucose - The present invention discloses the use of extracts from the plants of the genus 01-28-2010
20120015053TREATMENT OF PSORIASIS - This invention relates to compositions, and methods of use thereof, for treating conditions associated with elevated arginase levels and/or activity comprising administering to a subject in need thereof, certain polyphenols such as flavanols, procyanidins, or pharmaceutically acceptable salts or derivatives thereof.01-19-2012
20100034904COMPOSITION COMPRISONG RUTIN AND POLYUNSATURATED FATTY ACID HAVING AN INHIBITORY ACTIVITY ON 5-ALPH REDUCTASE - The present invention relates to the use of selected active principles of a natural origin in substitution of extract from Boehmeria Nipononivea for regulating the trophism of hair follicles and the production of sebum on the skin and its use in alopecia, with considerable practical advantages and with respect to the safety profile.02-11-2010
20100098783APPETITE SUPPRESSANT COMPOSITION - A chewable appetite suppressant composition includes a 04-22-2010
20080241280Usage of the Plant of Genus Ampelopsis and Extracts Thereof For Manufacture of Medicament and Functional Food - Usage of the plant of genus 10-02-2008
20120058206ANTIALLERGIC MARINE BIOPOLYMERS - The present invention relates to pharmaceutical compositions for administration to the respiratory tract, the gastrointestinal tract or the eyes. In particular, the invention relates to liquid formulations and dry powder compositions comprising carrageenan, and in particular iota and kappa carrageenan, and one or more therapeutic agents. These sprays, powders, and the gel that forms when they are administered to the respiratory tract, the gastrointestinal tract or the eyes, have now surprisingly been found to be a very effective way of prevention and treatment of type I allergies and intranasal administration of therapeutic agents.03-08-2012
20100266715COMPOSITION FOR TREATING AIDS AND ASSOCIATED CONDITIONS - An Aids and associated conditions related to Aids treating compositions is disclosed. The compositions comprise: a medicament selected from an extract of at least one of the following plant families: Apocynaceae (Pleioscarpa Bicarpellata); Annonaceae (Cleistopholis Patens); Dichapetalaceae (Dichapetehan Madagasca Riense); Annoceae (Uvaristrum Pierreanum); Cynocynaceae (Strophantus Gratus); Asclepiadaceae (Gongronema Latifolium); Combretaceae (Combretum Racemosum); Apocynaceae (Alostonia Boonei); Amaranthaceae (Alternanthera Pungens); Aroceae (Anchomanes Differmis); Cyperaceae (Seleria Voivinil); Anacardiaceae (Lannea Acida); Bignoniaceae (Kigelia Africana); Bombacaceae (Ceiba Pentanota); Anarcardiaceae (Antrocaryon Micraster); Bombacaceae (Bombax Bounopozense): Anarcardiaceae (Spondias Mombin); Caricaceae (Carica Papaya); a glyceryl ester of any of the foregoing extracts; a saponin of any of the foregoing extracts; an alkaloid of any of the foregoing extracts; a protein of any of the foregoing extracts; a fat of any of the foregoing extracts; a sugar of any of the foregoing extracts; and any mixture of any of the foregoing.10-21-2010
20090148542Composition comprising an extract of tiarella polyphylla and tiarellic acid isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity - The present invention relates to a composition comprising an extract of 06-11-2009
2012015631411 beta, 13-DIHYDROHELENALIN DERIVATIVES AND USES THEREOF AS BOMBESIN RECEPTOR SUBTYPE 3 AGNOISTS - The present invention relates to compounds of formual (I):06-21-2012
20120156315Composition for Treating Vitiligo or Canities Comprising Extract from Sophora Japonica as Active Ingredient - Disclosed is a composition for treating or preventing vitiligo or canities comprising 06-21-2012
20090220622USE OF MIMOSINE OR A DERIVATIVE THEREOF FOR TREATING THE CUTANEOUS EFFECTS OF PSORIASIS AND RELATED SKIN DISORDERS, AND COSMETIC OR PHARMACEUTICAL COMPOSITION CONTAINING SAME - The present invention relates to the use of mimosine or a derivative thereof for treating the cutaneous effects of psoriasis and related skin disorders.09-03-2009
20110091583ANTIALLERGIC MARINE BIOPOLYMERS - The present invention relates to pharmaceutical compositions based on carrageenan as an active ingredient, for use as a medicament in the prophylactic or therapeutic treatment of allergic conditions or diseases, with the proviso that the carrageenan comprises iota- and/or kappa-carrageenan and is substantially free of lambda carrageenan. Typically, the invention relates to liquid formulations, gels and dry powder compositions comprising iota- and/or kappa-carrageenan and, optionally, one or more non-carrageenan therapeutic agents for administration to the respiratory tract, the gastrointestinal tract or the eyes. The compositions of the invention have been found to be efficacious in the prevention and treatment of type I allergies and additionally, may exert an adjuvant function upon combined mucosal administration with non-carrageenan therapeutic agents.04-21-2011
20110091582Method for Obtaining Concentrated Polyphenol Extracts From a Stirring Process - The present invention proposes methods for obtaining concentrated polyphenol extracts resulting from the stirring process, through a step in which a partially purified beer is placed into contact with a resin that adsorbs the polyphenols, followed by a step in which the polyphenols adsorbed onto said resin are recovered. The invention also relates to the extracts thus obtained, which feature remarkable properties, as well as to several applications for these extracts.04-21-2011
20110091580EXTRACT OF ROSMARINUS OFFICINALIS L. LEAVES FOR PHARMACEUTICAL APPLICATIONS - Disclosed are methods of alleviating oxidative stress, regulating blood glucose levels, and controlling pancreatic lipase activity by administering a Rosemary extract. Such methods may be useful to help body weight and body fat, prevent obesity, and treat hyperglycemia, hyperinsulinemia, cardiovascular disease and Type-2 diabetes. Preferred extracts contain 20% or 50% carnosic acid.04-21-2011
20100291243EXTRACTOR HAVING POTTERY WITH A DARK BROWN GLAZE AND THE METHOD FOR EXTRACTING USING THEREOF - Disclosed are an extractor having a “pottery with dark brown glaze” called “Onggi” in Korean, and a method of extracting using the same. The extractor includes a body, a body cover, a heating part, a pottery and a gas valve. The pottery is located within the body. The extractor extracts by injecting nitrogen gas, etc. into the body through a gas valve, thereby rendering the inside of the body to be high pressure state during extraction. Thus, the inside of the body is maintained under high pressure during extraction. Accordingly, an extract is located only within the pottery, and thus changes that can be caused while an extract contacts with the body can be prevented.11-18-2010
20100055210COSMETIC COMPOSITION FOR PROTECTING SKIN AGAINST UV LIGHT AND WRINKLE IMPROVEMENT CONTAINING THE EXTRACT OF MAGNOLIA SIEBOLDII FLOWER EXTRACTS - Disclosed herein is a cosmetic composition for preventing photoaging, containing an extract of 03-04-2010
20090274779Use in the cosmetics field of an extract of an exsudate of the plant daniellia oliveri, in particular as an antiwrinkle agent - The invention relates to the use, in a cosmetic composition or for the production of a cosmetic composition, of an extract of an exsudate of the plant 11-05-2009
20080317878Herbal Therapy for the Treatment of Food Allergy - The present invention provides herbal formulas, and compositions thereof, that can treat or reduce the severity, intensity, or duration of food allergy and food allergyrelated symptoms. The compositions may optionally include one or more adjuvants, cytokines, encapsulating materials, or pharmaceutically acceptable carriers or excipients, and may be administered prior to, during, or after the development of food allergy-related symptoms in a patient in need thereof.12-25-2008
20100092581ANTIBACTERIAL COMPOSITIONS COMPRISING AN EXTRACT FROM ARCEUTHOBIUM - This application relates to an antibacterial composition comprising an extract from a plant belonging to the genus 04-15-2010
20120164245METHOD OF TREATMENT OF NEURODEGENERATIVE OR NEURO-MUSCULAR DEGENERATIVE DISEASES AND THERAPEUTIC AGENT TO TREAT THE SAME - Use of high doses above 1 gm per day of ascorbic acid or the derivatives thereof for the treatment of neurodegenerative and neuro-muscular degenerative diseases and disorders, in particular amytrophic lateral sclerosis, multiple sclerosis, alzheimer's disease, parkinson's disease, and muscular dystrophy is disclosed. Preferably the dose includes mannitol which facilitates the delivery of ascorbic acid to the target cells in the brain. Still further the said dose includes zinc citrate for preventing formation of kidney stones. Dose compositions for various routes of application such as oral, intravenous, intramuscular, nasal and in the form of transdermal patches are discussed.06-28-2012
20120164244COMBINATION OF PROANTHOCYANIDINS AND CENTELLA ASIATICA FOR THE TREATMENT OF ATHEROSCLEROSIS - The invention relates to a preparation for medical purposes and more specifically to a preparation consisting of the combination of proanthocyanidins such as Pycnogenol or grape seeds and 06-28-2012
20120164240ENRICHED A. BLITOIDES COMPOSITIONS AND USES THEREOF - Embodiments of the inventions described herein provide, among other things, enriched 06-28-2012
20120164242NOVEL METHODS FOR MODULATING MELANIN PRODUCTION - Methods are provided for modulating pigmentation and melanin production by administering an extract of 06-28-2012
20120164241BOEHMERIA EXTRACT AND ITS USE IN TREATING LIVER DISEASES - A pharmaceutical composition prepared from a 06-28-2012
20100215780Method for treating onychoschizia - The present invention is directed to compositions containing a combination of a herb from the genus 08-26-2010
20090130236ANTI-MICROBIAL AGENT AND ANTI-MICROBIAL COMPOSITION - The present invention relates to an anti-tetanic agent comprising a Sasa extract; an anti-fungal agent comprising a Sasa extract and an organic acid; an anti-viral agent comprising a Sasa extract; an anti-microbial agent comprising 05-21-2009
20120128798Method of Treating Neurological Conditions with Extract of Nerium Species or Thevetia Species - A method of treating neurological condition in a subject by administration of an extract, or fraction or sub-fraction thereof, of 05-24-2012
20120128799Soft Dried Marshmallow and Method of Preparation - Dried soft aerated confections and methods of their preparation are provided having a water activity of about 0.1 to 0.4 and a glass transition temperature of less than 20° C. The confections comprise sugars, a foaming and a structuring ingredient, preferably each gelatin, and about 5 to 15% softening agent. Preferred softening agents include glycerin, polyglycerols and mixtures thereof. The confections are aerated to densities of about 0.1 to 0.5 g/cc. The soft dried aerated confections are particularly suited for addition to children's Ready-To-Eat cereals in the form of pieces weighing about 0.1 to 2 g each. The dried confection pieces maintain their soft texture over time without causing moisture migration to the cereal.05-24-2012
20120128797METHOD FOR TREATMENT OF CONSTIPATION-PREDOMINANT IRRITABLE BOWEL SYNDROME - The present invention provides methods for treating constipation-predominant irritable bowel syndrome comprising administering to a patient in need thereof, a polymeric proanthocyanidin composition from a 05-24-2012
20120128796Extracts and Compounds from Ficus Benghalensis for Increasing Hair Growth and Decreasing Hair Loss - This application discloses natural product extracts and compounds from an aerial root of a 05-24-2012
20100209542Methods For Treating Withdrawal From Addictive Compounds08-19-2010
20110183014PRODUCT CONTAINING EXTRACT FROM ZANTHOXYLUM AVICENNAE (LAM.) DC., AND PREPARATION PROCESS AND USE THEREOF - Disclosed herein are a product containing an extract from 07-28-2011
20120219643ANTI-NEOPLASTIC COMPOSITIONS COMPRISING EXTRACTS OF BLACK COHOSH - A method for treating, preventing or ameliorating breast cancer is provided by administering a synergistic amount of digitoxin and either actein or an extract of black cohosh comprising triterpene glycosides, and optionally another chemopreventive agent which may be paclitaxel. Methods for treating or preventing a neoplasia using a synergistic combination, and compositions of a synergistic combination of a cardiac glycoside and either actein or an extract of black cohosh comprising triterpene glycosides, and optionally another chemopreventive agent which may be a taxane are also provided. The compositions may also be used in a method for modulating Na08-30-2012
20100330208APPARATUS AND PROCESS FOR EXTRACTION OF CONSTITUENTS FROM ALTERNATIVE MEDICINAL MATERIAL - An apparatus and process as a system for extraction of constituents from alternative medicinal material is provided. The apparatus includes an outer container containing a solvent liquid, an inner container mounted within the outer container containing an alternative medicinal material, a microwave generator for supplying microwaves to the solvent liquid and the alternative medicinal material, and a motor for rotating the inner container within the outer container. The inner container includes a perforated wall, such that the alternative medicinal material in the inner container can be fully or partially immersed in the solvent liquid.12-30-2010
20090280195Methods for the treatment of addictive disease and addiction to chemical substances and addictive behaviors using a formula containing the following formulation: Mucuna pruiens, N Acetyl L Cysteine, Magnesium Citrate - The invention is directed at the formulation of 11-12-2009
20120213868OIL-EXTRACTED PRODUCT OF INDIGO NATURALIS, AND PREPARATION PROCESS AND USES THEREOF - Disclosed herein are an oil-extracted product of indigo naturalis, and the preparation process thereof. Also disclosed are a pharmaceutical composition containing the oil-extracted product of indigo naturalis and a method for treating a human subject having or suspected to have a psoriatic disease such as skin psoriasis and nail psoriasis.08-23-2012
20120076874COMPOSITION WITH IMPROVED BIOAVAILABILITY OF SAPONIN AND METHOD FOR IMPROVING THE BIOAVAILABILITY OF SAPONIN (AS AMENDED) - The present invention relates to a 03-29-2012
20100047370PHARMACEUTICAL COMPOSITION WITH ANTIFUNGAL ACTIVITY CONTAINING CYMBOPOGON NARDUS, ITS PROCESS, AND USE - The present invention refers to the application of extracts of 02-25-2010
20080213404Hif Modulating Compounds and Methods of Use Thereof - A method is provided for treating subjects, including humans, with infection or virulence by pathogens. The method involves administering an agent in amounts effective to eradicate or reduce infections and/or an inflammatory response caused by pathogens. Methods for identifying compounds useful as anti-infectives that decrease the immune resistance, virulence, or growth of microbes are also provided. More particularly, there are provided methods for identifying compounds which increase accumulation or stability or activity, or alternatively decrease the degradation of HIF-1a protein.09-04-2008
20120177754INHIBITOR OF INFLAMMATORY CONDITIONS - The invention relates to 07-12-2012
20080206365Diterpene compounds having an atisane framework, compositions thereof, and methods of production - Provided are a certain compounds and compositions useful for inhibiting or activating the production of various types of cytokines. Also provided are certain compounds and compositions for preventing or treating various diseases attributable to abnormal cytokine production or compromised immunity.08-28-2008
20100272831PROCESS FOR MANUFACTURING NANOCOMPOSITE MATERIALS FOR MULTISECTORAL APPLICATIONS - The present invention relates to a process for manufacturing intercalated nanocomposites with a layered structures, characterized in that they contain intercalated food, pharmaceutical or medical contact compliant organic materials and comprises the following steps: 10-28-2010
20100034905Method of treating burns - In a first aspect, the present invention provides compositions for treating burns. The compositions, containing effective amounts of a processed 02-11-2010
20090053330PROCESS FOR PREPARATION OF RHUS VERNICIFLUA EXTRACTS HAVING EXCELLENT ANTI-CANCER ACTIVITY AND ANTI-CANCER PHARMACEUTICAL COMPOSITION CONTAINING THE SAME - Provided is a process for preparation of a 02-26-2009
20120225136INHIBITION OF TUMOUR CELL MIGRATION - The invention relates to the use of a cannabis plant extract or a cannabinoid as a pharmaceutically active agent in the inhibition of tumour cell migration.09-06-2012
20100009017Anticancer Methods Using Extracts of Anemarrhena asphodeloides Bunge - Selective apoptotic extracts of 01-14-2010
20090061025COMPOSITIONS AND METHODS FOR TREATING DEMODEX INFESTATIONS - Compositions containing about 0.6% to about 20% of tea tree oil are described. Some compositions are in the form of solutions, suspensions, spray, lotions, gels, pastes, medicated sticks, balms, cleansers (including shampoos and soaps), creams, or ointments. Also described are compositions and methods for use in treating ocular Demodex infestations and related conditions using such compositions.03-05-2009
20090061026NUTRACEUTIC PREPARATION IN POWDER FORM CONTAINING FREE PLANT STEROLS - The present invention relates to a nutraceutical preparation containing, in the same unit dose, a dried powder comprising free plant sterols in the global quantity of 0.5 to 3.0 g. The preparation preferably also contains red yeast rice, soluble natural fibres and natural antioxidant compounds, the latter generally being carried by products deriving from fruit and/or vegetables. The invention also relates to the process for its preparation, and the use of the preparation in foodstuffs to reduce and control the cholesterol level, mainly in the blood.03-05-2009
20120082737Topical Skin Care Formulations Comprising Plant Extracts - Disclosed are compositions and corresponding methods of their use that include extracts from a 04-05-2012
20120189721METHODS AND COMPOSITIONS FOR HEAVY METAL DETOXIFICATION - Compositions and methods for enhancing heavy metal detoxification are described. The compositions and methods described provide enhanced activity of key detoxification systems including that the induction of phase II detoxification enzymes, such as glutathione S-transferases (GSTs), and NADPH quinone reductase (NQO1) activity.07-26-2012
20120189722DIETARY SUPPLEMENT STIMULATING THE MALE SEXUAL FUNCTION - The present invention relates to dietary supplements comprising 07-26-2012
20120189720METHOD FOR TREATMENT OF DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME - The present invention provides methods for treating diarrhea-predominant irritable bowel syndrome comprising administering to a patient in need thereof, an inhibitor of chloride-ion transport in an amount sufficient to treat diarrhea-predominant irritable bowel syndrome (d-IBS). Treatment of d-IBS includes the treatment of the diarrhea component of d-IBS as well as the pain, abdominal discomfort and other symptoms associated with d-IBS. In one embodiment, the inhibitor of chloride-ion transport is crofelemer.07-26-2012
20090022820COMPOSITIONS FOR STERILIZING SPORES OF SPORE -FORMING MICROORGANISMS COMPRISING THE EXTRACTS OF TORILIDIS FRUCTUS - Disclosed are a composition comprising an organic acid extract of Torilidis Fructus, which has a sterilization effect on spores of spore-forming microorganisms including fungi and bacteria, and a method of sterilizing spores and vegetative cells using the composition.01-22-2009
20100068309METHOD OF EVALUATING SKIN BARRIER FUNCTION, METHOD OF SCREENING MATERIAL FOR ENHANCING SKIN BARRIER FUNCTION USING THE EVALUATING METHOD, THE MATERIAL FOR ENHANCING SKIN BARRIER FUNCTION, AND COSMETIC CONTAINING THE MATERIAL FOR ENHANCING SKIN BARRIER FUNCTION - A method for developing an excellent material for enhancing skin barrier function, and providing a cosmetic which is developed based on the method and has excellent ability to enhance skin barrier function is described. The method evaluates skin barrier function by the steps of 1) culturing normal human epidermal cells in wells having a semipermeable membrane with two sides, in presence and absence of a test substance; 2) adding a medium not containing metal ions to a first side of the semipermeable membrane in each well and a medium containing the metal ions to a second side of the semipermeable membrane in each well, provided that the cells are adhered to the first side of the semipermeable membrane; 3) culturing the cells; 4) measuring the concentration of the metal ions in each medium; and 5) calculating permeability of the metal ions in the epidermal cell layer based on the measured concentrations of the metal ions in each media. The test substance is effective for enhancing skin barrier function when the permeability is reduced in the medium in which the test substance is added compared to the permeability in the medium in which no test substance is added. The larger the level of reduced permeability, the higher the suitability of the test substance as a material for enhancing skin barrier function.03-18-2010
20120258182SYNERGISTIC COMPOSITIONS AND METHODS - Pharmaceutical compositions for oral administration comprising a therapeutically effective amount of a synergistic combination of lycopene and at least one phytosterol wherein the ratio of said lycopene to said phytosterol in said pharmaceutical composition is a maximum of about 5:1 and wherein said composition produces a synergistic inhibition of cell growth are disclosed.10-11-2012
20090017143Composition for treatment of alcoholism - A composition effective in the treatment of alcoholism comprising one or more alcohol craving blocker components such as Kudzu and Rhodiola Rosea, one or more antidepressant components such as St. John's Wort (Hypericin), 5-Hydroxytryptophanm SAMe, Melatonin and Taurine, and/or one or more anti-anxiety components such as Vitamin B complex, Glutamine, Niacin, SAMe, Hops, Melatonin and Rhodiola Rosea, the components chosen such that in combination they beneficially affect the nutritional, physiological and psychological deficiencies that combine to cause alcohol dependency.01-15-2009
20090017140MAYTENUS ABENFOLIA EXTRACT AND METHODS OF EXTRACTING AND USING SUCH EXTRACT - A method of inhibiting COX-2, inhibiting NF-Kappa B activation, treating inflammation, or treating cancer may comprise administering a therapeutically effective amount of an extract of 01-15-2009
20100166891Composition comprising hemp oil for treating topical diseases, especially hand-foot syndrome - The invention relates to a novel composition comprising hemp oil for treating topical diseases, in particular the hand-foot syndrome.07-01-2010
20110123647USE OF EXTRACTS OF CAPRARIA BIFLORA IN THE PREVENTION AND/OR TREATMENT OF SENILE CATARACTS - The invention provides methods for treating and/or preventing the recurrence of a senile cataract, and/or for inhibiting the development of a senile cataract and/or an incipient senile cataract, in a human or animal subject. The invention further provides nutraceutical compositions suited for the same, derived from an extract of the plant 05-26-2011
20110123646Extracts Obtained from Cell Line Cultures from Plants Belonging to the Oleaceae Family (e.g. Syringa Vulgaris), Their Preparation and Use - The present invention refers to the use of extracts from selected and stabilised cell lines comprising phenylpropanoids with high anti-oxidant capacity having a verbascoside titre of between 20% and 90% and a chromophore-free fraction of between 80% and 10%, in human and veterinary medicine, and for nutritional and cosmetic purposes.05-26-2011
20120231093METHOD FOR PREPARING NANO-SCALE OR AMORPHOUS PARTICLE USING SOLID FAT AS A SOLVENT - The present invention relates to a method for preparing nanoscale or amorphous particles using solid fat as a solvent. According to the present invention, nanoscale or amorphous particles of active ingredients are prepared by using fat as a solvent, wherein the fat is in solid phase at room temperature. The nanoscale or amorphous particles of active ingredients can be advantageously used in medicine, cosmetics, functional foods or the like.09-13-2012
20120231094Hair Shape Susceptibility Gene - A genetic polymorphism and a hair shape susceptibility gene that are related to hair shape, and a method for determining the genetic susceptibility to hair shape in individual test subjects are provided. Disclosed is a hair shape susceptibility gene, which overlaps with a haplotype block in the 1q32.1 to 1q32.2 region (D1S249 to D1S2891) of human chromosome 1 and comprises a portion or the entirety of the base sequence of the haplotype block, wherein the haplotype block is determined by a linkage disequilibrium analysis conducted on a single nucleotide polymorphism (SNP) marker whose allele frequency differs statistically significantly between a group having a curly hair trait and a group having a non-curly hair trait, and consists of a base sequence set forth in any one of SEQ ID NO:1 to NO:3.09-13-2012
20080299230Oil formulations and methods of use - The invention generally relates to various oil formulations for protecting plants from nematodes and other pathogens. The invention provides specific formulations which do not require the use of chemical additives. These formulations have low phytotoxicity and low volatility. Also, methods of applying the formulations for agricultural use are disclosed.12-04-2008
20080299231HERBAL COMPOSITION FOR TREATMENT OF NEURODEGENERATION AND NEURONAL DYSFUNCTION - This invention provides methods of using various herbal compositions to treat neurodegenerative diseases and neuronal dysfunctions, said compositions comprise a combination of Radix angelica sinensis (DangGui), Ligusticum chuanxiong (ChuanXiong), Hirudo (ShuiZhi), Polygonatum sibiricum (HuangJing), Carthamus tinctorius (Hong Hua), Astragalus membranaceus (HuangQi), and Glycyrrhiza uralensis (Gancao).12-04-2008
20080299229METHODS OF REDUCING BETA-AMYLOID POLYPEPTIDES - The invention features methods of reducing the level of a β-amyloid (Aβ) polypeptide using an 12-04-2008
20110003018COMPOSITION FOR PREVENTING AND TREATING ARTHRITIC DISEASES - In some embodiments, a composition for the treatment and inhibition or prevention of arthritic diseases includes an extract of mixed herbs, the mixed herbs including an active ingredient with 01-06-2011
20120263804Essential element extractor - A Mobile Extractor for extracting essential elements from plant material and for transporting low concentrations of essential elements in a solution of solvent includes a clean tank, a hopper, one or more pumps, a plurality of valves, and a dirty tank. Plant material may be soaked or rinsed with a solvent that extracts essential elements from the plant material where the solvent washes the essential elements from the plant material into a dirty tank. When the operation is complete the dirty tank will contain a solution of solvent infused with essential elements from the plant material. The best mode of the invention extracts cannabinoid or 10-18-2012
20120328718PHARMACEUTICAL COMPOSITIONS - The present invention relates to an improved mode of administration for cannabis and its natural and synthetic derivatives. A pharmaceutical composition suitable for sublingual aerosol or spray delivery of cannabis is provided. The formulation may be dispensed using a pump spray or the formulation may include a propellant, such as butane, 1,1,1,2-tetrafluoroethane (HFC-134a) or 1,1,1,2,3,3,3-heptafluoropropane (HFC-227). The term cannabis is used herein to refer to all physiologically active substances derived from the cannabis family of plants and synthetic cannabis analogues and derivatives, precursors, metabolites etc., or related substances having cannabis-like physiological effects.12-27-2012
20110038960PREPARATION AND USE OF A PLANT EXTRACT FROM SOLANUM GLAUCOPHYLLUM WITH AN ENRICHED CONTENT OF 1,25-DIHYDROXYVITAMIN D3 GLYCOSIDES AND QUERCETIN GLYCOSIDES - The present invention relates to the preparation of an enriched and equilibrated plant extract from 02-17-2011
20110038959PLANT-ORIGIN DRUG FOR PREVENTING OR IMPROVING HYPERURICEMIA - This invention provides an agent for preventing or ameliorating hyperuricemia comprising, as an active ingredient, an extract of at least one type of plant raw material selected from the group consisting of 02-17-2011
20110038958USE OF CANNABINOIDS IN COMBINATION WITH AN ANTI-PSYCHOTIC MEDICAMENT - The present invention relates to the use of one or more cannabinoids in combination with one or more anti-psychotic medicaments for use in the prevention or treatment of psychosis and psychotic disorders. Preferably the one or more cannabinoids are taken from the group: cannabidiol (CBD); cannabidiolic acid (CBDA); tetrahydrocannbidivarin (THCV); tetrahydrocannbidivarinin acid (THCVA); cannabichromene (CBC); cannabichromenic acid (CBCA); cannabigerol (CBG) and cannabigerolic acid (CBGA). Preferably the anti-psychotic medication is an atypical anti-psychotic medication.02-17-2011
20110045106COFFEE EXTRACT - The present invention relates to a method of producing a coffee extract with antioxidant and anti-inflammatory properties and uses of the extract of the invention. The coffee extract comprises caffeic acid and/or ferulic acid and can be produced by hydrolysing chlorogenic acids present in coffee extract, e.g. with a microorganism or an enzyme. The coffee extract of the invention may e.g. be used as an ingredient of a food or beverage product.02-24-2011
20110045105COSMETIC USE OF AN OPHIOPOGON JAPONICUS ACTIVE PRINCIPLE - The use of at least one extract that is obtained from 02-24-2011
20120269908CARRIER IN OIL-IN-WATER EMULSION FORM, PARTICULARLY FOR COSMETIC OR DERMATOLOGICAL USE - The present invention relates to a carrier in oil-in-water emulsion form, containing a very small amount of a surface-active agent so that the emulsion is stable, well-tolerated, and nonirritating. The present invention also relates to a method for preparing a carrier according to the invention and to the use of such a carrier as a base for compositions to be applied onto sensitive human or animal body tissue, particularly in dermatological or dermocosmetic compositions.10-25-2012
20100233299TOPICAL PHYTOTHERAPEUTIC COMPOUND FOR THE TREATMENT OF HERPES BASED ON UNCARIA TOMENTOSA AND EXTRACTION PROCESS FOR OBTAINING A VEGETAL EXTRACT FROM UNCARIA TOMENTOSA - The present invention concerns a phytotherapic compound for the treatment of herpes based on 09-16-2010
20120321726Berberine-containing pharmaceutical composition for inhibiting cancer stem cell growth or carcinoma metastasis and application thereof - A pharmaceutical composition for inhibiting cancer stem cells growth or carcinoma metastasis and an application thereof are disclosed. The pharmaceutical composition includes: a berberine compound; and a pharmaceutically acceptable carrier. The application is the use of the berberine compound in the manufacture of a medicament for the inhibition of cancer stem cell growth or carcinoma metastasis.12-20-2012
20120087995NFAT Signal Inhibitor and Calcineurin Inhibitor - To provide a drug, an external use composition, and a cosmetic composition, which exhibit an NFAT signal inhibitory action, a calcineurin inhibitory action, and a hair growth-promoting effect.04-12-2012
20100203174PET FOOD COMPOSITION FOR REGULATING BODY WEIGHT AND PREVENTING OBESITY AND RELATED DISORDERS IN PETS - The invention relates to a pet food composition for regulating body weight and preventing obesity and related disorders in pets, which comprises as an active ingredient at least one plant or plant extract having the ability to stimulate energy expenditure and/or fat burning. The invention also relates to a method for improving the health of pets, particularly by preventing obesity and metabolic disorders associated with obesity in pets. It also relates to a method for increasing energy expenditure, controlling the glucose homeostasis and improving activity or mobility of the pet.08-12-2010
20100221363PROCESS FOR THE PRODUCTION OF A STORAGE STABLE FUNGICIDAL EXTRACT OF GLYCYRRHIZA GLABRA FOR THE CONTROL OF PHYTOPATHOGENIC FUNGI AND OTHER PLANT DISEASES - Plant diseases of crops cause huge economic losses in agricultural and ornamental production as well as in public green. Effective management and control of the disease is a major problem and a big challenge for the agricultural production. Applications (in the form of sprays) of extracts derived preferably from the aboveground parts of the 09-02-2010
20110159120SYNERGISTIC ANTI-INFLAMMATORY COMPOSITIONS COMPRISING BOSWELLIA SERRATA EXTRACTS - The present invention discloses synergistic nutraceutical or pharmaceutical or dietary supplement anti-inflammatory compositions comprising therapeutically effective combination of an extract selectively enriched in 3-O-acetyl-11-keto-β-boswellic acid (AKBA) derived from 06-30-2011
20110159119COMPOSITIONS AND METHODS FOR ARACHNID CONTROL - The invention provides compositions and methods for treating or preventing infestation of a site with a spider.06-30-2011
20110159118Screening Method (Metabolite Grid) for Therapeutic Extracts and Molecules for Diabetes - The present invention provides therapeutic compositions derived from plants useful for treating diabetes. The present invention also provides methods for screening plant metabolites and constituents to identify therapeutic agents and/or dietary supplements for treating diabetes. The therapeutic compositions can be derived from plants such as 06-30-2011
20080268072Method of Improving Anticancer Effect of Pulsatillae Radix and a Composition Prepared by the Method - The present invention relates to a composition enriched with 3-0-[O-α-L-rhamnopyranosyl-(1→2)-[0-β-D-glucopyranosyl-(1-→4)]-α-L-arabinopyranosyl]hederagenin (Code No. SB 365) of which antitumor activity is very strong by enzyme-reacting and extracting Pulsatillac radix.10-30-2008
20080254151 HERBAL MIXTURE EXTRACT OF REHMANNIAE RADIX PREPARATA AND ACANTHOPANACIS CORTEX AND A COMPOSITION COMPRISING THE SAME FOR PREVENTION AND TREATMENT OF OSTEOPOROSIS - The present invention relates to a herbal mixture extract of Rehmanniae Radix Preparata and Acanthopanacis Cortex and a composition comprising the same for the prevention and treatment of osteoporosis.10-16-2008
20080254150Management of dermatitic symptoms of mammalian integument with emollient disinfectant formulations - Botanically-sourced and botanically-derived emollient sanitation compositions for topical use are disclosed. Representative compositions generally aid reconstitution of the lipid profile of the stratum corneum by providing botanical lipids and/or lipid-derivatives that resemble human sebum—these components being ordinarily diminished with the use of conventional hand sanitizer products. Disclosed features and specifications may be variously controlled, adapted or optionally modified to realize, for example, improved hand sanitizer formulations. Representative embodiments of the present invention generally provide anti-microbial compositions blended with botanically sourced lipids and/or lipid-derivatives to control or otherwise improve dermatitic symptoms associated with frequent use of conventional hand sanitizer products.10-16-2008
20080254149Recovery of Residual Plant Components After Distillation of Essential Oils - Methods for recovering valuable compounds and substances from plants after distillation of oils are disclosed. The methods involve various aqueous and non-aqueous solvent extraction of plant material from which oils have been distilled previously.10-16-2008
20100068311Preparation, process and a regenerative method and technique for prevention, treatment and glycemic control of diabetes mellitus - A medicinal preparation, a process, a nutritional composition and regenerative and insulin potentiating method for humans and also for mammals for prevention, treatment and management/glycemic control of diabetes mellitus by obtaining optimum glucose level in blood, by administering an extract of 03-18-2010
20080241283Aqueous extracts of anoectochilus spp. kinsenoside-comprising pharmaceutical compositions useful for hepatoprotection and uses of the same - A pharmaceutical composition useful for hepatoprotection is provided. The composition comprises an effective amount of kinsenoside or a pharmaceutically acceptable salt or ester thereof. An aqueous extract of 10-02-2008
20080233216Composition Comprising the Extract of Siegesbeckiae Herba For Preventing and Treating Arthritis and the Use Thereof - The extract of Siegesbeckiae herba of the present invention showed potent inhibitory effect on the dissociation of proteoglycan and type II collagen in chondrocyte and cartilage tissue and protecting effect on cartilage due to the inhibition of MMP-1, MMP-3 and MMP-13 activity and the restoring effect on cartilage tissue, the anti-inflammatory and antiphlogistic effect in edema animal model, anti-inflammatory effect confirmed by the inhibition test on PGE09-25-2008
20080226755Composition to enhance the bioavailability of curcumin - A composition for enhanced bioavailability of curcumin including purified curcuminoid and purified essential oil of turmeric. A method to prepare a composition for enhanced bioavailability of curcumin having purified curcuminoid and purified essential oil of turmeric.09-18-2008
20080226753Method of Reducing Insect Resistant Pests in Transgenic Crops - The present invention discloses Resistance Management (RM) practices that are critical to safeguarding 09-18-2008
20110262567COMPOSITION FOR TREATING GOUT, CONTAINING ANGELICA GIGAS EXTRACT HAVING A XANTHINE OXIDASE-INHIBITING EFFECT AND AN INFLAMMATION-INDUCING ENZYME-INHIBITING EFFECT - The present invention relates to a composition for the treatment of gout, comprising an Angelica gigas Nakai extract which inhibits xanthine oxidase to reduce uric acid in the blood or urine, thereby being effective in the treatment of gout.10-27-2011
20110262566NOVEL USEFUL THERAPEUTIC AGENT FOR LOWER URINARY TRACT SYMPTOM - Provided is a therapeutic agent for lower urinary tract symptom consisting of (+)-3-{1-[3-(trifluoromethoxy)benzyl]piperidin-4-yl}-4-phenyl-3,4-dihydro-2(1H)-quinazolinone or a pharmaceutically acceptable salt thereof or a combination of (+)-3-{1-[3-(trifluoromethoxy)benzyl]piperidin-4-yl}-4-phenyl-3,4-dihydro-2(1H)-quinazolinone or a pharmaceutically acceptable salt thereof and a compound selected from the group consisting of α10-27-2011
20130177661Saussurea Involucrate Extract, Pharmaceutical Composition and Use for Anti-Fatigue and Anti-Aging - Disclosed are a 07-11-2013
20080220097FORMULATIONS CONTAINING CYNARA SCOLYMUS AND PHASEOLUS VULGARIS EXTRACTS WHICH ARE USEFUL IN THE TREATMENT OF OBESITY - The present invention relates to a 09-11-2008
20130136808PLANT-DERIVED FORMULATIONS FOR TREATMENT OF HIV - Disclosed herein are methods for treating mammals with HIV/AIDS comprising administering a therapeutically effective amount of a composition comprising an extract of 05-30-2013
20130115317Method for Identifying Pre-Biotics and Compositions Containing the Same - A method for indentifying test agents that exhibit prebiotic activity on companion animal skin commensal microorganisms and dermatological compositions that include such agents. The method includes providing a test culture of a test agent, a companion animal skin commensal microorganism and a minimal carbon medium. The method provides a time efficient and cost effective way to predict in vivo prebiotic activity of a test agent on skin commensal microorganisms.05-09-2013
20130171274COSMETIC COMPOSITION FOR IMPROVING SKIN ELASTICITY - Provided is a cosmetic composition for improving skin elasticity containing 07-04-2013
20130115316INDOLEALKYLAMINO-WITHASTEROID CONJUGATES AND METHOD OF USE - A group of indolealkylamino-withasteroid conjugates, isolated and purified from 05-09-2013
20130101689COMPOSITION CONTAINING PAPER MULBERRY EXTRACTS - The present invention relates to a composition containing a paper mulberry extract, and more particularly to a composition containing, as an active ingredient, a paper mulberry extract which has effects on enhancement of skin moisturization, inhibition of skin aging, alleviation of inflammation, antibacterial activity, pore size reduction, sebum control, skin complexion improvement, decomposition of subcutaneous fat, stimulation of melanin synthesis, and gray hair prevention.04-25-2013
20130101687INSECTICIDAL COMPOSITIONS AND METHODS OF USING THE SAME - Insecticidal compositions have at least one active agent and at least one insecticide. The active agent can include 04-25-2013
20130101688HERBAL COMPOSITION PHY906 AND ITS USE IN CHEMOTHERAPY - This invention provides herbal compositions useful for increasing the therapeutic index of chemotherapeutic compounds. This invention also provides methods useful for improving the quality of life of an individual undergoing chemotherapy. Furthermore, this invention improves the treatment of disease by increasing the therapeutic index of chemotherapy drugs by administering the herbal composition PHY906 to a mammal undergoing such chemotherapy.04-25-2013
20080279967Composition and method for increasing the metabolism of free fatty acids and facilitating a favorable blood lipid - A dietary supplement comprising at least an effective amount of 11-13-2008
20130142889COMPOSITION COMPRISING THE EXTRACT OF PHYSALIS ALKEKENGI VAR. FRANCHETI HORT AS AN ACTIVE INGREDIENT FOR PREVENTING AND TREATING INFLAMMATORY DISEASES - The present invention is related to the inventive compositions comprising the extract of Physalis alkekengi var francheti Hort showing potent anti-inflammatory effect through various experiments, therefore, it can be used as the effective and safe therapeutics or health food for treating and preventing inflammatory diseases06-06-2013
20110223263ANTIOXIDANT COSMETIC COMPOSITION CONTAINING EXTRACT OF PROCESSED PEONY, POLYGONATI RHIZOMA OR LILY - The present invention relates to an antioxidant cosmetic composition, and more particularly to an antioxidant cosmetic composition containing, as an active ingredient, either an extract of at least one of peony, Polygonati rhizoma and lily, processed using a medicinal herb processing technique, or a mixture of said extract and an extract of at least one of unprocessed peony, Polygonati rhizoma and lily.09-15-2011
20090041869METHOD OF REDUCING INSECT RESISTANT PESTS IN TRANSGENIC CROPS - The present invention discloses Resistance Management (RM) practices that are critical to safeguard 02-12-2009
20130136807INSECT PROOF AND INSECTICIDAL COMPOSITION FOR THE CONSERVATION OF CULTURAL PROPERTY COMPRISING Asarum sieboldii EXTRACT OR A FRACTION THEREOF AS AN ACTIVE INGREDIENT - Disclosed herein is an insect proof or insecticidal composition for the conservation of cultural properties against termites, comprising an extract of 05-30-2013
20110236509TOPICAL COMPOSITION COMPRISING EXTRACTS OF A. INDICA AND M. CHARANTIA OR S. INDICUM - The invention relates to a topical composition and a method for reducing or preventing occurrence of acne on the skin. It is an object of the present invention to provide for a combination of herbal extracts that interact synergistically to provide a cosmetic composition for prevention, reduction or treatment of acne. The present invention provides for a topical composition comprising (i) an extract of a first active which is 09-29-2011
20120276224COMPOUND COMPRISING EXTRACTS OR FRACTIONS OF CHRYSANTHEMUM BOREALE MAKINO HAVING ANTI-INFLAMMATION ACTIVITY - The present invention relates to a composition having an anti-inflammatory activity, comprising extracts or fractions of 11-01-2012
20120276223COMPOSITION FOR PREVENTING AND TREATING INFLUENZA-VIRUS-INDUCED DISEASES - The present invention relates to a medicinal extract useful for preventing and treating influenza-virus-induced diseases, and to a pharmaceutical composition and health food including same. Derived from natural ingredients, the medicinal extract of the present invention is safe for humans, and can be used to prevent, treat, and alleviate symptoms of diseases induced by various strains of influenza viruses.11-01-2012
20130149397Modulation of Thymosin Beta-4 in Skin - Methods for preventing, ameliorating, or reducing dermatological signs of aging are provided which employ active agents, other than a retinoid, that stimulate thymosin beta-4 expression in the skin. Also provided are methods for screening for substances which stimulate thymosin beta-4 expression levels and the methods of using active agents identified by the screening protocol in the treatment of skin.06-13-2013
20100285155CLEANSER COMPOSITION AND METHODS FOR USING THE SAME - The present invention is directed to anti-microbial cleanser compositions comprising linalool, hinokitiol and dipropylene glycol. The present invention further provides methods for using these compositions to maintain eyelid hygiene, to treat an ocular disorder or to clean a skin surface. The cleanser compositions of the present invention can be in the form of a foam, gel or liquid.11-11-2010
20100291242ANTAGONIST AGAINST TOLERANCE TO ANTICANCER DRUGS - An ABC transporter protein expression inhibitor comprising, as the active ingredient(s), 0.001 to 100 nM of one or more members selected from among steroid hormones, compounds having a female hormone function, analogous compounds thereof and antagonistic inhibitors therefor; an anticancer composition containing this ABC transporter protein expression inhibitor and an anticancer drug; and cells useful in the development of an anticancer drug. The present invention provides a drug which inhibits the expression of an ABC transporter to thereby overcome resistance to anticancer drugs; cancer cells useful in screening such drugs; and an anticancer drug efficacious even against such a cancer as having acquired resistance to anticancer drugs.11-18-2010
20100316738METHODS OF INHIBITING, PREVENTING, KILLING AND/OR REPELLING INSECTS USING SIMULATED BLENDS OF CHENOPODIUM EXTRACTS - The present invention provides natural and/or simulated, synthetic, synergistic pesticidal compositions comprising terpenes, such as extracts from 12-16-2010
20100316736APPETITE SUPPRESSANT - Provided is an extract of 12-16-2010
20120282354COMPOSITION FOR PREVENTING OR TREATING DISEASES CAUSED BY INFLUENZA VIRUSES - The present invention relates to herbal medicine extracts useful in the prevention or treatment of diseases caused by influenza viruses, and to a pharmaceutical composition or health food comprising the extracts. The herbal medicine extracts of the present invention are derived from natural materials, and are safe for the human body, and can be used in preventing and treating and in relieving symptoms of diseases caused by various types of influenza viruses.11-08-2012
20130183390SYNERGISTIC PESTICIDE COMPOSITIONS - The present invention relates to compositions that include a combination of one or more pesticides and one or more adjuvants.07-18-2013
20090304826Method and composition for dermatoses - The invention provides a method and composition for treating dermatoses by topical application of a composition containing an antihistamine, an NSAID and optionally a botanical medicinal compound. The compositions are useful for skin conditions such as inflammatory skin conditions, including eczema, atopic dermatitis, non-allergic dermatitis, psoriasis and rosacea, or any inflammation of the skin.12-10-2009
20130122121METHOD OF USE OF AN ANTI-METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS AGENT AND AN ANTI-VANCOMYCIN-RESISTANT ENTEROCOCCUS AGENT - Methods of use of an anti-methicillin-resistant 05-16-2013
20110311655Further preparations of silk proteins, seed oils, monosaccharide, natural botanicals and polysaccharide mixtures in compositions for hair care or hair repair, and skin care and topical treatments - The present invention intends to provide a composition for hair and skin treatment containing a combination consisting of silk amino acid and protein complexes, seed oils, polysaccharides, polyol, monosaccharide, and botanicals. The composition for hair and skin treatment containing the combination consisting of silk amino acid and protein complexes, seed oils, polysaccharides, and botanicals has excellent improvement effects on the condition of the hair follicle and cuticle, imparts moisture to dry hair; thereby reducing the damaging effects of psoriasis, eczema, alopecia, and seborrheic dermatitis. Furthermore, it imparts retention of moisture to the skin resulting in an improved appearance and diminished appearance of lines on the skin. This invention relates to the manufacture of personal care products to be applied to the hair and skin. The compositions may be in the form of hair conditioners, hair growth treatments, shampoos, skin care, skin cleansing, or anti-wrinkle products, and ointments.12-22-2011
20120288575CLEANSER COMPOSITIONS AND METHODS FOR USING THE SAME - The present invention is directed to anti-microbial cleanser compositions comprising linalool, hinokitiol and dipropylene glycol. The present invention further provides methods for using these compositions to maintain eyelid hygiene, to treat an ocular disorder or to clean a skin surface. The cleanser compositions of the present invention can be in the form of a foam, gel or liquid.11-15-2012
20120015054EXTRACT OF EUODIA SUAVEOLENS SCHEFF, REPELLENT COMPOSITIONS AND USE THEREOF - The invention relates to an extract of 01-19-2012
20080199542Use of Winter Savory (Satureja Montana) or the Extracts Thereof For the Preparation of Medicaments For the Treatment of the Premature Ejaculation - The use of Winter savory or its purified extracts rich in rosmarinic acid, the use of rosmarinic acid and the extracts containing it for the preparation of medicaments for the treatment of premature ejaculation.08-21-2008
20120021075DUAL-CHAMBER PACKAGING SYSTEMS FOR CANNABIS-INFUSED PRODUCTS SYSTEMS - A dual-chamber packaging for medical marijuana-infused products and edibles providing individuals who are suffering from various health problems and diseases with an effective method for ingesting and/or topically applying medical marijuana. The invention may comprise a dual-compartmental containment device made from high-density polyethylene. The two chambers may be separate but are encased in one outer container. Professionally manufactured goods, such as lotions or oils with THC and CBD enhancers and carriers and other beneficial properties, can be kept in the first compartment, while cannabinoid fluid may be contained in the second compartment. For use in transdermal delivery of cannabinoids, an individual may first dispense the professionally-developed material and rub it onto his/her skin. Dispensaries may customize the materials used in this device to satisfy the needs dictated by their patients' specific conditions or diseases. The device provides for the possibility of transporting partially professionally produced products not only within the state, but also to the states where medical marijuana is legal (while they are not filled with cannabinoids.)01-26-2012
20120027878NATURAL LYCOPENE CONCENTRATE AND METHOD FOR PRODUCTION THEREOF - Natural lycopene concentrate obtained from a plant structure after alkalinization, solid-liquid separation, acidification and a second solid-liquid separation. The concentrate obtained is highly bioavailable and water-soluble at room temperature.02-02-2012
20130196003CLASS OF ANTI-ADHESION HYDROGELS WITH HEALING ASPECTS - Disclosed are hydrogels polymerized with a biofunctional moiety, biodegradable and permanent, designed to be implantable in a mammalian body and intended to block or mitigate the formation of tissue adhesions. The hydrogels of the present invention are characterized by comprising four structural elements: a) a polymeric backbone which defines the overall polymeric morphology, b) linkage groups, c) side chains, and d) biofunctional end groups. The hydrophobicity of the various structural elements are chosen to reduce tissue adhesion and enhance the biofunctional aspect of the end groups. The morphology of these polymers are typically of high molecular weight and have shape to encourage entanglement. Useful structures include branching chains, comb or brush, and dendritic morphologies.08-01-2013
20130202722Treatment of Neurocutaneous Syndrome, Including Compositions, Methods and Uses Thereof - A treatment protocol for use in the treatment of neurocutaneous syndrome is described and comprises at least one xanthone component, which may comprise at least one mangosteen component, and at least one detoxification component. Additional embodiments comprise at least one herbal component, at least one vitamin component, or a combination thereof. A method of treating a patient having neurocutaneous syndrome is described herein and comprises: providing at least one xanthone component, which may comprise at least one mangosteen component, providing at least one xanthone component, which may comprise at least one mangosteen component, to the patient, and administering the at least one detoxification component to the patient. Additional methods steps may include providing and administering at least one herbal component, providing and administering at least one vitamin component or a combination thereof.08-08-2013
20120076873Health Food - The object of the present invention is to consume raw food cultivated in appropriate soil.03-29-2012

Patent applications in class PLANT MATERIAL OR PLANT EXTRACT OF UNDETERMINED CONSTITUTION AS ACTIVE INGREDIENT (E.G., HERBAL REMEDY, HERBAL EXTRACT, POWDER, OIL, ETC.)

Patent applications in all subclasses PLANT MATERIAL OR PLANT EXTRACT OF UNDETERMINED CONSTITUTION AS ACTIVE INGREDIENT (E.G., HERBAL REMEDY, HERBAL EXTRACT, POWDER, OIL, ETC.)